Research
Investor Market Map
A structured view of longevity capital, mapping investors, funds, family offices, and ecosystem capital providers by geography, thesis, focus areas, key people, and available profile evidence.
| Investor | Investor type | HQ | Investment focus | Profile / thesis | Known portfolio companies | Key people | Target groups | Links |
|---|---|---|---|---|---|---|---|---|
| 25M Health | Adjacent longevity investors | New York, United States | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care delivery | 25M Health is a healthtech venture studio and early-stage venture fund that incubates and invests in businesses offering innovative solutions to improve healthcare outcomes and make communities healthier. They focus on digital health, B2B healthcare IT, and B2B2C tech-enabled care delivery, primarily investing from Pre-seed to Series A in the United States. | Basalt HealthCanopyFlourishHandspring HealthLadderMidiSwap HealthTruehold | Kirk Posmantur, Chief Partnership Officer, Board Member, FounderFannie Chen, Chief Operating OfficerGrant Silow, General PartnerJamie Brown, Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| .406 Ventures | Adjacent longevity investors | Boston, United States | Core preventive health | .406 Ventures is an early-stage venture capital firm based in Boston, focusing on healthcare, data + AI, and cybersecurity. The firm is relevant to preventive health through its investments in disruptive healthcare solutions aimed at improving delivery and outcomes. | AbleToIora HealthBluebird Kids HealthFamilyWell | Trip Hofer, Venture PartnerGraham Brooks, PartnerGreg Dracon, PartnerJoanna Skoler Gilman, Chief Marketing and Communications Officer | Startups / Founders (B2B)Professional & Institutional Investors | |
| 5AM Ventures | Adjacent longevity investors | San Francisco, United States | Pharma/Drug discovery | 5AM Ventures is a leading investment firm focused on funding and building next-generation life sciences companies. They invest across biopharmaceuticals, drug delivery technologies, and life science instruments, aiming to solve important healthcare needs. | AchaogenCage TherapeuticsLifordi ImmunotherapeuticsFellowNvelop Therapeutics | Arthur Tzianabos, Venture PartnerBrian Daniels, Venture PartnerElliott Levy, Venture PartnerAndy J. Schwab, Managing Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| 7Wire Ventures | International longevity VCs | Chicago, United States | Core preventive health | 7wire Ventures is a Chicago-based venture capital firm that invests in early-stage to later-stage digital health companies. The firm's core thesis is to empower the "Informed Connected Health Consumer" by investing in technology-driven solutions that enhance healthcare delivery and consumer engagement, directly supporting preventive health and improved outco | LivongoNOCDFOLX HealthParsley HealthHomethriveWhen Insurance | Startups / Founders (B2B)Professional & Institutional Investors | ||
| Able Partners | Adjacent longevity investors | New York City, United States | Core preventive health | Able Partners is an early-stage consumer investment fund based in New York City, focused on health and wellness. The firm aims to support entrepreneurs building visionary brands that enhance consumers' daily lives by addressing the "Wellness Gap" in physical and mental health. | AlmaAlto NeuroscienceAmae HealthSeason HealthFunction HealthDUOSOura Ring | Alison Ryu, PartnerAmanda Eilian, Founding PartnerLisa Blau, Founding Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Accel | Adjacent longevity investors | Palo Alto, United States | Core preventive health | Accel is a global venture capital firm that partners with exceptional teams from inception through all phases of private company growth, primarily focusing on early- and growth-stage technology companies. The firm has demonstrated a clear interest in the preventive health and longevity sector, making strategic investments in companies aiming to extend human | Generation LabBioPeakAtlassianSlackSpotifyFlipkartFacebookDropbox | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| AEVIS VICTORIA | Adjacent longevity investors | Fribourg, Switzerland | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care deliveryConsumer health & wellness | Aevis Victoria is a Swiss investment holding company that focuses on the high-value sectors of healthcare, hospitality, lifestyle, and infrastructure. Its core holdings include the Swiss Medical Network, one of the country's leading private clinic groups, and Nescens, a premier brand dedicated to better-aging and longevity medicine. | Not captured | Not captured | Clinics / Labs / Medical Professionals (B2B)Founded 2006 | |
| AF Ventures | Adjacent longevity investors | New York, United States | Wellness Platforms | AF Ventures is a venture capital fund investing in high-growth consumer product companies. The firm focuses on emerging growth stage businesses across food & beverage, health & wellness, personal & household care, beauty, and pet, with a clear relevance to preventive health through its focus on healthy living-oriented brands and wellness platforms. | ByHeartHello CakeJinxSiete Family FoodsGainfulCirkulHims & HersYumi | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| age1 | International longevity VCs | San Francisco, United States | BiotechPharma/Drug discovery | age1 is a venture capital firm based in San Francisco, United States, focused on extending healthy human lifespan by investing in early-stage longevity biotech companies. The firm aims to revolutionize global healthcare systems by preventing age-related diseases rather than solely treating them. | ALX OncologyLoyalGordian BiotechnologySpring DiscoveryUnity BiotechnologyDecibel Therapeutics | Laura Deming, Co-Founder, Venture PartnerAlex Colville, Co-Founder, General PartnerCarol Magalhaes, NewCo Chief of StaffSatvik Dasariraju, Principal | Startups / Founders (B2B)Professional & Institutional Investors | |
| Airtree VC | Adjacent longevity investors | Sydney, Australia | BiotechCore preventive healthWellness Platforms | Airtree VC is a network-powered venture capital firm based in Sydney, Australia, investing in early-stage technology companies across Australia and New Zealand. The firm demonstrates a clear interest in health tech, personalized healthcare, and founder well-being, aligning with preventive health and wellness platforms. | HumanMr YumCanva | Anil Sabharwal, Venture PartnerAdrielle Touma, Investment Manager | Startups / Founders (B2B)Professional & Institutional Investors | |
| AlbionVC | Adjacent longevity investors | London, United Kingdom | Core preventive health | AlbionVC is a UK-based venture capital firm established in 1996, managing approximately £1 billion in venture funds and investing in over 50 companies. The firm focuses on seed to Series B investments in B2B software, healthcare, and deeptech companies, with a significant emphasis on healthtech solutions that contribute to preventive health. | OvivaEllipticQuantexaAbcodia | Adam Chirkowski, PartnerAndrew Elder, Deputy Managing PartnerCat McDonald, PartnerChristoph Ruedig, Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Alven | Adjacent longevity investors | Paris, France | Biotech | Alven is an independent early-stage venture capital firm based in Paris, France, with over 25 years of experience. The firm primarily invests in European technology startups at the Seed and Series A stages, focusing on a broad range of sectors including marketplaces, AI, fintech, and wellness brands, which aligns with preventive health through its health tec | StripeQontoTypologyGorgiasYuboKestraGenerareVerley | Charles Letourneur, Managing PartnerFrançois Meteyer, PartnerGuillaume Aubin, Managing PartnerMaria Tahri, Principal | Startups / Founders (B2B)Professional & Institutional Investors | |
| Amboy Street Ventures | International longevity VCs | Los Angeles, United States | Core preventive health | Amboy Street Ventures is a venture capital fund based in Los Angeles, United States, that focuses on Seed and Series A investments in Women's Health and Sexual Wellbeing for all genders. The firm aims to address the untapped $1 trillion market opportunity in these areas, making it highly relevant to preventive health by supporting innovations in fertility, c | EvvyContralineAlloyBea FertilityHeyJaneTestmateGranata BioAunt Flow | Dominnique Karetsos, Venture PartnerMafe Pereza Godoy, Venture PartnerCarli Sapir, Founding PartnerColleen Foster, Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Amino Collective | International longevity VCs | Berlin, Germany | BiotechCore preventive health | Amino Collective is an early-stage venture capital firm based in Berlin, Germany, specializing in health and biotechnology investments. The firm focuses on European ventures with global ambitions, backing entrepreneurs and scientists in pre-seed and seed rounds. Its investment thesis aligns with preventive health through its focus on digital health, personal | AllcyteAnimaAwareAwellBiomia | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| aMoon | Adjacent longevity investors | Ra'anana, Israel | Biotech & aging scienceDigital health & AIClinics & care delivery | aMoon is a global HealthTech and Life Sciences investment fund based in Israel, partnering with entrepreneurs to transform healthcare through groundbreaking science and technology. The fund invests in early and late-stage companies, focusing on biopharma, digital health, and medical technology to accelerate cure and promote a proactive, personalized approach | OmadaIbexAtaCor MedicalMDClone | Isaac Devash, Venture PartnerSamuel Moed, Venture PartnerNoah Lasson, JD, Chief Compliance Officer & CISOOsnat Tirosh, Chief People Officer & Chief of Staff | Startups / Founders (B2B)Professional & Institutional Investors | |
| Ananda VC | Adjacent longevity investors | Munich, Germany | BiotechCore preventive health | Ananda Impact Ventures is a leading European impact venture capital firm based in Munich, Germany, focused on early-stage technology-driven startups. The firm invests across various scales, from planetary to molecular, with a strong emphasis on solutions that improve people's health and quality of life, making it relevant to preventive health and longevity. | iesoClose Loop MedicineOroraTechNatureMetricsDifferential BioResistomap | Alina Bassi, PrincipalBernd Klosterkemper, PartnerFlorian Erber, General Partner & FounderJohannes Weber, General Partner & Founder | Startups / Founders (B2B)Professional & Institutional Investors | |
| Andera Partners Life Sciences | International longevity VCs | Paris, France | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care delivery | Andera Partners Life Sciences is a venture capital fund based in Paris, France, specializing in investments in companies developing breakthrough therapeutic products and medical technologies. The fund targets innovative medical solutions from preclinical stages to commercialization across Europe and the US. | Alveus TherapeuticsInventivaSpiro MedicalAbivax | Loan Hoang-Sayag, Venture PartnerThierry Hercend, Venture PartnerAneta Sottil, PartnerElyes Chouaieb, Investment Director | Startups / Founders (B2B)Professional & Institutional Investors | |
| Andreessen Horowitz (a16z) | Adjacent longevity investors | Menlo Park, United States | BiotechPharma/Drug discovery | Andreessen Horowitz (a16z) is a prominent venture capital firm with a dedicated Bio + Health fund, investing in founders who are redefining medicine and healthcare. They focus on multidisciplinary leaders driving medical breakthroughs, tackling diseases, and building modern healthcare infrastructure, with a strong emphasis on leveraging AI and engineering bi | BenchlingMindstrongRoSana BiotechnologyNautilus BiotechnologyPatientPingClair HealthInsitro | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Apex Ventures | Adjacent longevity investors | Vienna, Austria | BiotechPharma/Drug discovery | Apex Ventures is a European deep-tech and medical-focused venture capital firm based in Vienna, Austria. The firm invests in early-stage companies, primarily at the pre-seed, seed, and Series A stages, with a mission to build the next generation of world's leading companies. Their focus on medical and deep-tech solutions, including biotechnology and medical | contextflow | ANDREAS RIEGLER, General PartnerWOLFGANG NEUBERT, General Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Apollo Health Ventures | International longevity VCs | Berlin, Germany | BiotechPharma/Drug discovery | Apollo Health Ventures is a transatlantic early-stage Venture Capital firm that actively co-founds and invests in transformative healthcare companies. Their investment focus is on age-related diseases and aging itself, aiming to enhance healthy lifespans through scientific breakthroughs in biotechnology and health tech. | Auron TherapeuticsTherini BioHAYA TherapeuticsAeovian PharmaceuticalsThymofoxOchre BioRefoxy Pharmaceuticals | Alexandra Bause, Co-Founder & Venture PartnerChris Shepard, Venture PartnerGerd Hummel, Venture PartnerAntoine Boulanger, Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Archangel Ventures | Adjacent longevity investors | Melbourne, Australia | Core preventive health | Archangel Ventures is an Australian venture capital firm that provides pre-seed and seed funding, as well as early-stage venture capital, to technology startups across Australia and Southeast Asia. The firm has a notable focus on health tech, aiming to support companies that drive innovation and improve healthcare efficiency. | Heidi HealthAtelierPearlerRelevance AIEarth Blox | Andrew Cicutto, PartnerBen Armstrong, Managing PartnerRayn Ong, PartnerGrace Liang, Head of Investor Relations and Operations | Startups / Founders (B2B)Professional & Institutional Investors | |
| Arkitekt Ventures | International longevity VCs | New York, United States | BiotechCore preventive health | Arkitekt Ventures is an early-stage venture fund based in New York, United States, specializing in novel models of healthcare delivery and frontier technology applications to medicine. The firm invests in visionary entrepreneurs transforming cutting-edge science and technology into solutions that radically improve and advance human health, with a strong rele | CofertilityOlli HealthStandard Model BiomedicineMural HealthTiaNaniteParsley HealthNOVOS | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| ARTIS Ventures | Adjacent longevity investors | San Francisco, United States | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care deliveryConsumer health & wellness | ARTIS Ventures is a venture capital firm that partners with founders advancing global resilience through critical technologies that heal, protect, and sustain society. They focus on TechBio and Frontier Tech, leveraging AI and engineered technologies across various stages of venture investment. | PalantirEkoCohesityConceivable Life Sciences | Austin Walne, Senior PartnerHenry Klingenstein, PartnerJeff Sheedy, PartnerKash Chandarana, Co-Founder Luxe Brand Assets; Alma Hotel Management | Startups / Founders (B2B)Professional & Institutional Investors | |
| Asabys Partners | International longevity VCs | Barcelona, Spain | Biotech | Asabys Partners is a Barcelona-based investment firm focused on fostering breakthrough innovation in healthcare and life sciences. They invest in disruptive and transformative technologies with the aim of improving patients' lives, including solutions relevant to diagnostics and therapeutic care. | Binx HealthXR HealthAccure TherapeuticsAgomabInbrain NeuroelectronicsGradient Denervation Technologies | Clara Campàs, Co-founder and managing partnerEmilio Erazo-Fischer, Operating PartnerGuillem Masferrer, PartnerJose María Fernández, Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Ascension VC | International longevity VCs | London, United Kingdom | BiotechConsumer TechCore preventive health | Ascension VC is a London-based early-stage venture capital firm that invests in pre-seed and seed technology startups across the UK, with a focus on mission-driven and impact-oriented founders. The firm has a dedicated interest in HealthTech, making it relevant to preventive health and longevity research. | Credit Kudos | Chris Wheatcroft, Investment PartnerEmma Steele, PartnerIulia Tudor, Ascension Fund III PartnerJean de Fougerolles, Managing Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Ascension Ventures | Adjacent longevity investors | St. Louis, United States | Core preventive health | Ascension Ventures is a strategic healthcare venture fund and innovation catalyst with over $1 billion in capital under management. It focuses on investing in smarter technologies, bigger data, better alternatives, and healthier futures within the healthcare ecosystem. | Strive HealthClarify HealthLivongoMedically Home | Jamie Wehrung, Chief Administrative OfficerEmily Kuhns, Finance DirectorJohn Kuelper, Senior Managing DirectorPooja Goel, Managing Director | Startups / Founders (B2B)Professional & Institutional Investors | |
| ASICS Ventures | Adjacent longevity investors | Kobe, Japan | Core preventive health | ASICS Ventures is the corporate venture capital arm of ASICS, established to accelerate innovation in sports through investments and collaborations with cutting-edge technology startups globally. Its investment focus aligns with ASICS' "VISION2030" to promote healthy and fulfilled lives, making it relevant to preventive health and longevity. | PICKLEBALL ONECurv HealthOME Health | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Athletic Ventures | Adjacent longevity investors | Sydney, Australia | Core preventive health | Athletic Ventures is a venture capital firm and community of current and former elite athletes based in Sydney, Australia. It invests in high-growth technology and consumer companies, primarily at Seed and Series A stages, with a focus on generating financial returns and providing education for athletes. | TeamworksEucalyptusSploseGuzman y GomezPet CircleHnryWho Gives A CrapHeaps Normal | Matt de Boer, Co-FounderMatt Dellavedova, Co-FounderCathleen Santoso, Head of Platform | Startups / Founders (B2B)Professional & Institutional Investors | |
| Atlas Venture | Adjacent longevity investors | Cambridge, United States | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care delivery | Atlas Venture is a biotech-focused venture capital firm based in Cambridge, Massachusetts, that specializes in creating and investing in early-stage biotechnology and therapeutics companies. The firm employs a science-first, patient-centric approach to drug development, aiming to translate groundbreaking science into life-changing medicines. | AAVantgarde BioAffinia TherapeuticsObsidian TherapeuticsVitae Pharmaceuticals | Akshay Vaishnaw, MD, Venture PartnerBob Copeland, Venture PartnerBruce Booth, DPhil, PartnerDavid Grayzel, Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Atomico | Adjacent longevity investors | London, United Kingdom | BiotechCore preventive health | Atomico is a European venture capital firm headquartered in London, investing in ambitious technology companies from early-stage to pre-IPO. The firm demonstrates relevance to preventive health through its focus on Medtech & Digital Health, supporting companies that aim to proactively improve health outcomes and leverage cutting-edge technology for personali | Hinge HealthHealxNourishPomelo CareNeko HealthKlarnaDeepL | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Auxxo Female Catalyst Fund | Adjacent longevity investors | Berlin, Germany | Core preventive health | Auxxo Female Catalyst Fund is a Berlin-based venture capital fund that invests in pre-seed and seed-stage, female (co-)founded startups across Europe. The fund is sector-agnostic but has a portfolio that includes companies relevant to preventive health through advancements in biotech and sustainable healthcare solutions. | BioOrbitBIOVOXEmidatFiluAnybillBeams | Bettine Schmitz, General PartnerDr. Gesa Miczaika, General Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| B2venture VC | Adjacent longevity investors | St. Gallen, Switzerland | BiotechCore preventive health | B2venture is a European early-stage venture capital firm that invests in innovative ideas and startups, leveraging a unique network of angel investors. The firm primarily focuses on pre-seed, seed, and Series A rounds across various sectors, including digital health and healthcare, making it relevant to preventive health and longevity. | NellyMMIWellhubDeepLSumUpAraris Biotech | Andreas Goeldi, PartnerAnna Bosch, PrincipalChristian Schütz, PartnerAnna Rösler, Head of Platform | Startups / Founders (B2B)Professional & Institutional Investors | |
| Backed VC | Adjacent longevity investors | London, United Kingdom | BiotechCore preventive healthPharma/Drug discovery | Backed VC is a human-centric European seed fund based in London, investing $500K-$5M in brave founders building generation-defining frontier tech companies from pre-seed to growth stages. With a clear focus on healthtech and biotechnology, including drug discovery, the firm is highly relevant to the preventive health and longevity sectors. | Novogaiadeveloping RNA medicines to treat, delay, and prevent diseases) | Alexey Morgunov, Bio Venture PartnerAlex Brunicki, Co-Founder and General PartnerAndre de Haes, Co-Founder and General PartnerLucia Cerchlan, Head of Founder Experience | Startups / Founders (B2B)Professional & Institutional Investors | |
| BBG Ventures | Adjacent longevity investors | New York, United States | Core preventive healthWellness Platforms | BBG Ventures is an early-stage venture fund based in New York, focused on investing in startups with female or diverse founders who are building solutions for a polycultural future. The fund targets companies addressing significant societal shifts, including those in healthcare transformation and wellness platforms, making it relevant to preventive health an | Maia OncologyOovaFiveableEvvyGrayceIcon Savings Plan | Claire Biernacki, PartnerNisha Dua, Managing Partner and Co-FounderSusan Lyne, Managing Partner and Co-FounderCarol Magalhães Isaacs, Senior Associate | Startups / Founders (B2B)Professional & Institutional Investors | |
| Bessemer Venture Partners | Adjacent longevity investors | San Francisco, United States | BiotechCore preventive health | Bessemer Venture Partners is a global venture capital firm with a long history, investing in audacious entrepreneurs from their early days through every stage of growth across various sectors including enterprise, consumer, and healthcare. The firm is highly relevant to preventive health and longevity through its dedicated focus on biotech and healthcare, ai | AbridgePivotal HealthHinge HealthOmada Health | Jeremy Levine, PartnerAnita Umarji, Investor RelationsElana Kuppermann, Investor RelationsEmily Cahill, Investor Relations | Startups / Founders (B2B)Professional & Institutional Investors | |
| B-Flexion | Family Offices & UHNW Investors | Genève, Switzerland | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care deliveryConsumer health & wellness | B-Flexion is a private, entrepreneurial investment firm that manages a diverse portfolio of operating businesses and asset managers with a core focus on life sciences, healthcare services, and digital health. The firm employs an active ownership philosophy, combining multi-generational family values with institutional private equity disciplines to drive long | Not captured | Sarah Crawford, Group CFO, Partner and Member of the BoardNithya Desikan, Operating Partner, B-Flexion Life SciencesPeter Agnes, Operating Partner, B-Flexion Life SciencesSteven Rotman, Operating Partner, B-Flexion Life Sciences | Startups / Founders (B2B)Founded 2012 | |
| BGF | Adjacent longevity investors | London, United Kingdom | Core preventive health | BGF is the most active equity investor in the UK and Ireland, providing long-term, minority investment to growing companies. It focuses on early to growth-stage investments across various sectors, including Life Sciences and Healthcare, making it relevant for preventive health and longevity research. | Cyted HealthEnhanced GenomicsTOrganOxIQ EndoscopesCellular OriginsArchus | Andy Gregory, Chief Executive OfficerBen Barker, Chief Investment OfficerAaron Baker, InvestorAdam Crinion, Investor | Startups / Founders (B2B)Professional & Institutional Investors | |
| BioGeneration Ventures | International longevity VCs | Naarden, Netherlands | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care deliveryConsumer health & wellness | BioGeneration Ventures (BGV) is a European venture capital firm specializing in early-stage investments in biotech, medtech, and diagnostics companies. The firm focuses on disruptive solutions for high unmet medical needs within the life sciences and healthcare sectors. | Acerta PharmaCitryllScenic BiotechAvidicureBrandaris TherapeuticsComplement TherapeuticsTargED Biopharmaceuticals | Rob de Ree, Venture PartnerDaniela Couto, PhD, General PartnerDiede Brunen, PhD, PrincipalEdward van Wezel, Managing Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| BioMedPartners | Adjacent longevity investors | Basel, Switzerland | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care deliveryConsumer health & wellness | BioMedPartners is a Basel-based venture capital firm that provides equity and mezzanine financing to early- and mid-stage healthcare and life science companies in the Alpine region. The firm focuses on biopharmaceuticals, medical devices, and diagnostics, leveraging a deep network and industry expertise to build innovative healthcare companies. | Not captured | Not captured | Startups / Founders (B2B)Health-Conscious ConsumersFounded 2002 | |
| Bioqube Ventures | International longevity VCs | Brussels, Belgium | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care delivery | Bioqube Ventures is a global life sciences investment firm, rooted in Europe with a global reach, that focuses on turning scientific discoveries into transformative medicines. The firm is stage-agnostic, supporting companies from inception through early clinical milestones, and invests in first- or best-in-class therapeutics to address major unmet medical ne | CatalYmPrimmune TherapeuticsCommit BiologicsEnhanced Genomics | Debora Dumont, Co-founder and Managing PartnerDirk Reyn, Managing Partner BFF INico Vandervelpen, Co-founder and Managing PartnerTessa Ceyssens, Chief Operating Officer (COO) | Startups / Founders (B2B)Professional & Institutional Investors | |
| Blue Ocean Ventures | Adjacent longevity investors | Plan-les-Ouates, Switzerland | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care delivery | Blue Ocean Ventures is a Geneva-based venture capital firm that specializes in early-stage investments in medical device and life science companies. The firm utilizes an "entrepreneur-for-entrepreneur" approach, providing startups with operational coaching, funding, and access to a global network of industry experts. | Not captured | Not captured | Startups / Founders (B2B)Founded 2008 | |
| Bluestein Ventures | Adjacent longevity investors | Chicago, United States | Biotech & aging scienceDigital health & AIClinics & care deliveryConsumer health & wellness | Bluestein Ventures is a family-based venture capital firm based in Chicago, United States, that invests in early-stage, game-changing ventures across the food industry. The firm focuses on companies that redefine how consumers achieve health and wellness, spanning Seed to Series A investment stages. | Factor | Lindsay Levin, Venture PartnerAndrew Bluestein, Co-Founder & Managing PartnerAshley Hartman, Managing PartnerAaditi Tamhankar, Associate | Startups / Founders (B2B)Professional & Institutional Investors | |
| BonAngels Venture Partners | Adjacent longevity investors | Seoul, South Korea | BiotechConsumer TechCore preventive healthWellness Platforms | BonAngels Venture Partners is a South Korean venture capital firm established in 2007, primarily focused on pre-seed and seed-stage investments in early-stage startups. The firm acts as a long-term partner, providing hands-on support and leveraging its entrepreneurial background to assist companies in achieving their visions, with a notable interest in deept | Lumia HealthPortraiWoowa BrothersVUNORebellions AIUniqconn | Jiyoung Park, PartnerJong-Il Yoon, PartnerKwangsoo Kim, Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Brandon Capital | International longevity VCs | Melbourne, Australia | BiotechPharma/Drug discovery | Brandon Capital is Australasia's leading life science venture capital firm, investing in biomedical opportunities from early-stage seed to expansion capital. The firm focuses on transforming medical research breakthroughs into therapies with the potential to improve patient lives and generate strong financial returns. | AdvancellAstronauTxAravax Pty LtdAxelia OncologyAzura OphthalmicsCatalYm | Alex Delbridge, PrincipalChris Nave, Founding Partner & Managing DirectorChris Smith, PartnerDom Marot, Chief Financial Officer | Startups / Founders (B2B)Professional & Institutional Investors | |
| BrandProject | Adjacent longevity investors | Toronto, Canada | Biotech & aging scienceDigital health & AIClinics & care deliveryConsumer health & wellness | BrandProject is a Toronto-based venture fund that partners with visionary founders to build iconic consumer brands. They invest in pre-seed and seed stage consumer product, service, and technology companies, with a specific focus on Health & Wellness and Performance Supplements, making them relevant to preventive health. | WonderbellyPeachyALOHAOwletRachel DroriCraig Dubitsky | Andrew Black, Founder, Managing PartnerChad Leger, CFO & Operating PartnerHayden Williams, PartnerChris Martone, Vice President | Startups / Founders (B2B)Professional & Institutional Investors | |
| Bullish | Adjacent longevity investors | New York, United States | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care deliveryConsumer health & wellness | Bullish is a New York-headquartered venture capital firm and marketing operating partner that invests in early-stage (Pre-Seed to Series A) disruptive consumer businesses and B2C propositions across the United States. The firm focuses on building category-defining consumer brands by integrating capital, strategic consulting, and creative services. | PelotonWarby ParkerHarry'sCasperHu ChocolateBubble SkincareDirty Labseasy-peasy | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Calm/Storm Ventures | International longevity VCs | Vienna, Austria | Core preventive health | Calm/Storm Ventures is a boutique venture capital firm and exclusive founder network based in Vienna, Austria, that invests in early-stage HealthTech companies across Europe and the US. The firm focuses on purpose-driven founders who are improving life, health, and wellbeing, with a strong emphasis on preventive health and digital health solutions. | Thymia | Ekaterina Gianelli, Venture PartnerPaul Varga, Venture PartnerHaymo Meran, Academy PartnerJohannes Blaschke, Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Capricorn Partners | Adjacent longevity investors | Leuven, Belgium | BiotechCore preventive healthWellness Platforms | Capricorn Partners is an independent European investment manager specializing in venture capital, growth capital, and quoted equity funds. The firm focuses on innovative companies leveraging digital, health, and clean technologies, aiming to create both financial returns and positive impact on people and the planet. | Sequana MedicalOgedaOska HealthXyall | Dick Sietses, Investment Partner HealthFilip Pintelon, Investment Partner HealthJos B. Peeters, Founding PartnerKatrin Geyskens, CEO | Startups / Founders (B2B)Professional & Institutional Investors | |
| Catalio Capital Management | Adjacent longevity investors | New York, United States | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care delivery | Catalio Capital Management is a New York-based investment firm focused on the full lifecycle of innovative healthcare investing, across private, public, and credit markets. It invests in breakthrough biomedical technology companies at all stages and sizes, often created or referred by an elite group of world-renowned scientist-entrepreneurs. | Bayesian HealthImperative CareArriVent BioPharmaThrive Earlier Detection | Adam Riess, Venture PartnerAlan Ashworth, Venture PartnerBarbara Slusher Ph.D., MAS, Venture PartnerBert Vogelstein, Venture Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Catalpa Ventures | International longevity VCs | Grevenmacher, Luxembourg | Core preventive health | Catalpa Ventures is an early-stage venture capital fund based in Luxembourg, investing in health-tech companies across Extended Europe. The firm focuses on digital innovations that address challenges posed by an aging society, labor shortages, and rising healthcare costs, making it highly relevant to preventive health and longevity. | Not captured | Adrian Goergen, PrincipalChristian Goergen, Founding & Managing PartnerSilke R. Sperling, Founding & Managing PartnerThomas Goergen, Founding & Managing Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Causeway Media | Adjacent longevity investors | Cambridge, United States | Consumer TechCore preventive healthWellness Platforms | Causeway Media is a growth equity firm based in Cambridge, Massachusetts, investing in growth-stage companies across sports, fitness, and related industries. With $390 million in capital under management, the firm focuses on advancing the consumer experience in these sectors, including wellness platforms relevant to preventive health. | FitOnFloSportsFormula EFreeleticsOmazePGA TOURZwift | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| CAVU Venture Partners | Adjacent longevity investors | New York, United States | Biotech & aging scienceDigital health & AIClinics & care deliveryConsumer health & wellness | CAVU Consumer Partners is a venture capital firm focused on investing in and building "better-for-you" consumer brands across various stages. The firm aims to democratize healthy living by supporting companies in the food, beverage, wellness, personal care, beauty, and pet sectors. | PoppiOnce Upon a FarmVital ProteinsThrive MarketBeyond MeatNoom | Bella Filer, Chief Financial OfficerBrett Thomas, Co-Founder & Managing PartnerJared Jacobs, Managing PartnerRohan Oza, Co-Founder & Managing Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Cherry Ventures | Adjacent longevity investors | Berlin, Germany | Core preventive health | Cherry Ventures is an early-stage pan-European venture capital firm founded in 2012, backing founders across Europe from pre-seed to Series A stages. The firm has invested in companies relevant to preventive health and longevity, such as Afilio and AMBOSS. | AfilioAMBOSS | Lutz Finger, Venture PartnerAlexander Langholz-Baikousis, CFO & Operating PartnerChristian Meermann, Founding PartnerDinika Mahtani, Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Chingona Ventures | Adjacent longevity investors | Chicago, United States | Core preventive healthWellness Platforms | Chingona Ventures is a Chicago-based venture capital firm that invests in pre-seed companies led by diverse founders. The firm focuses on industries undergoing significant change, including financial technology, future of work, future of learning, and health technology, making it relevant to preventive health and longevity. | Connect Care HeroDame ProductsTeal HealthBetterleaveBeni | Fernando Carranza, Senior PrincipalLori DeLuca, Chief Financial OfficerSamara Mejia Hernandez, Founding PartnerVeronica Crystal Mejia, Chief of Staff | Startups / Founders (B2B)Professional & Institutional Investors | |
| Civilization Ventures | International longevity VCs | San Francisco, United States | BiotechPharma/Drug discovery | Civilization Ventures is a San Francisco-based venture capital firm that invests in early-stage companies focused on essential innovations in healthcare and biology. The firm backs founders who are redefining human health and lifespan through preventative, personalized, and regenerative approaches. | RCKT)RewriteSingular BioBillionToOneOmada HealthForesight DiagnosticsLemonaid HealthCounsyl | Angelica Parente, Operating PartnerShahram Seyedin-Noor, Founder + Managing PartnerSonia Maryam Setayesh, PhD, Investment PartnerMatt Wheeler, CPA, CFO | Startups / Founders (B2B)Professional & Institutional Investors | |
| Cleveland Avenue | Adjacent longevity investors | Chicago, United States | Diagnostics & biomarkersDigital health & AIClinics & care deliveryConsumer health & wellness | Cleveland Avenue is a global venture capital firm that invests in lifestyle consumer brands and technology companies that positively disrupt large and growing markets. The firm aims to enhance consumers' lives through its investments, which include sectors relevant to preventive health like food & beverage and health & wellness. | HeroZerocaterPreciTasteNotCo | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Coefficient Capital | Adjacent longevity investors | New York, United States | Biotech & aging scienceDigital health & AIClinics & care deliveryConsumer health & wellness | Coefficient Capital is a New York-based venture capital and growth equity firm that invests in transformational consumer shifts, focusing on growth-stage consumer businesses. The firm's portfolio includes companies in CPG, food & beverage, and health & wellness, making it relevant to preventive health and longevity. | Kate FarmsLemmeTRIPSincerely YoursStarshipHYDRANTJust SpicesMagic Spoon | Andrew Goletka, Managing PartnerAnna Whiteman, PartnerArpon Ray, PartnerFranklin Isacson, Managing Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Collaborative Fund | Adjacent longevity investors | New York, United States | Core preventive health | Collaborative Fund is a New York-based venture capital firm established in 2010, focused on backing entrepreneurs who are advancing the world through businesses at the intersection of for-profit and for-good. The firm invests across various sectors including Consumer, AI, Money, Health, and Energy, with a particular interest in companies enabling healthier d | Blue Bottle CoffeeDaily HarvestImpossible FoodsLoveverySweetgreenOlipopWHOOP | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Corundum Neuroscience | International longevity VCs | Herzliya, Israel | BiotechCore preventive health | Corundum Neuroscience is an Israeli venture builder and fund dedicated to advancing transformative neuroscience solutions from lab to life. They focus on supporting cutting-edge neuroscience research and funding ambitious companies to bring life-changing solutions to market, with a strong emphasis on improving human health, longevity, and happiness. | NeuraWorxMyndliftNYX Technologies | Josh Schulman, Chief ScientistItsik Francis, Head of Business DevelopmentKarinna Moreno, Investment AnalystYhonatan Shemesh, Research Analyst | Startups / Founders (B2B)Professional & Institutional Investors | |
| Courtside Ventures | Adjacent longevity investors | New York, United States | SportsWellness Platforms | Courtside Ventures is a leading early-stage venture capital fund based in New York, United States. The firm focuses its investments on companies within the Sports, Lifestyle, and Gaming sectors, with a particular emphasis on areas relevant to preventive health such as personalized wellness and fitness platforms. | VeoJackpot Gaming100 ThievesStockX | Startups / Founders (B2B)Professional & Institutional Investors | ||
| Crista Galli Ventures | Adjacent longevity investors | London, United Kingdom | Biotech | Crista Galli Ventures is a physician-led venture capital firm based in London, United Kingdom, investing in early-stage European healthtech companies. They focus on TechBio, DeepTech Healthcare, and Digital Health, with a core thesis centered on shifting healthcare towards maintaining health and preventing pathogenesis. | Smart ReportingSubtle MedicalQuibimKeleyaSkin AnalyticsContextflow | Dr Fiona Pathiraja-Møller, Founder & Managing Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Crosscut Ventures | Adjacent longevity investors | Santa Monica, United States | Consumer TechCore preventive health | Crosscut Ventures is an early-stage venture capital firm based in Santa Monica, California, focused on investing in frontier technologies. The firm partners with founders building category-defining solutions to humanity's most pressing problems, including areas that can indirectly contribute to preventive health and well-being. | Umbra | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Cure Ventures | Adjacent longevity investors | Boston/Cambridge, United States | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care delivery | Cure Ventures is a life sciences venture capital firm based in Boston, Massachusetts, focused on de novo company formation and seed-stage drug discovery. The firm invests in groundbreaking curative technologies, aiming to bring life-changing therapeutics to patients. | XenImmuneAevum | Milenko Cicmil, Venture PartnerJeno Gyuris, PartnerMay Han, PartnerThe Latest Happenings, Founder Stories | Startups / Founders (B2B)Professional & Institutional Investors | |
| Deerfield Management | International longevity VCs | New York City, United States | Pharma/Drug discovery | Deerfield Management is an investment firm launched in 1994, dedicated to advancing healthcare through investment, intelligence, and philanthropy. The firm focuses on a diverse portfolio of private and public investments across the healthcare ecosystem, aiming to cure disease, improve quality of life, and reduce the cost of care. | Excelsior SciencesBluefin BiomedicineAscertainAtlas Data StoragePipeline Health | Abraham Kometz, PartnerAndrew ElBardissi, PartnerAnne Daub, PartnerBrian Bizoza, Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Define Ventures | International longevity VCs | San Francisco, United States | Core preventive health | Define Ventures is a venture capital firm based in San Francisco, United States, focused on early-stage digital health companies. The firm partners with entrepreneurs to leverage technology and redefine healthcare, with an emphasis on prevention, early intervention, and personalized care. | HIMS)Hims & HersFOLX Health | Bruce Broussard, Venture PartnerCarolyn Magill, Venture PartnerFrank Williams, Venture PartnerChirag Shah, Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Dementia Discovery Fund | International longevity VCs | London/Boston via SV Health Investors, United States | Biotech & aging scienceDigital health & AIClinics & care delivery | The Dementia Discovery Fund (DDF), managed by SV Health Investors, is the world's largest family of specialized venture capital funds exclusively investing in companies developing novel therapeutics for dementia. With offices in London and Boston, DDF invests across various stages to address the significant unmet medical need of dementia, which aligns with l | CerevanceAlector TherapeuticsNRG TherapeuticsAlchemab Therapeutics | Alex Badamchi-Zadeh, Vice President | Startups / Founders (B2B)Professional & Institutional Investors | |
| Digitalis Ventures | Adjacent longevity investors | New York, United States | Core preventive health | Digitalis Ventures is a venture capital firm based in New York that engineers solutions to unmet needs in health. The firm invests across all stages from pre-seed through growth in biotechnology, health technologies & services, and animal health, with a focus on improving human and animal health outcomes and reducing costs. Its investment strategy is highly | Alcea Therapeutics | Drew Taylor, Venture PartnerAmit Bansal, PartnerBen Jacobs, PartnerCindy Cole, Technical Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| District Ventures Capital | Adjacent longevity investors | Calgary, Canada | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care deliveryConsumer health & wellness | District Ventures Capital is a Canadian venture capital fund that invests in innovative companies within the food & beverage, health & wellness, and beauty sectors. Led by Arlene Dickinson, the fund primarily focuses on early-stage consumer packaged goods (CPG) companies, often providing pre-seed and seed funding. Its relevance to preventive health lies in i | Three Farmers Foods IncChickapeaFODY FoodsPremama WellnessJust VerticalNeo FinancialPocketpills | Arlene Dickinson, Partner & CFO | Startups / Founders (B2B)Professional & Institutional Investors | |
| DvH Ventures | Adjacent longevity investors | Köln, Germany | Core preventive healthWellness Platforms | DvH Ventures is a German venture capital firm that invests early in Europe's most passionate founders, focusing on dynamic entrepreneurs in various sectors. The firm manages multiple venture capital funds, including a dedicated €70 million Digital Health Fund, making it relevant for preventive health and longevity investments. | GardiaVirtonomyLiveEOLIQIDHypatosNectStudySmarterMasterplan | Cihat Cengiz, PrincipalDuc Quyen Tran, PartnerFabian von Trotha, Managing PartnerPeter Richarz, Managing Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Earlybird Health | International longevity VCs | Cologne, Germany | Biotech | Earlybird Health is a European venture capital investor focused on revolutionizing healthcare through early-stage investments in digital health, diagnostics, medical devices, R&D tools, and biopharma. The firm aims to enhance health outcomes and encourage preventive measures, supporting companies from initial development to commercialization across Europe. | Argá Medtech | Alexander Müller, Operating PartnerChristoph Massner, PartnerFlorent Gros, PartnerJohn Yianni, Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| East Ventures | Adjacent longevity investors | Singapore, Singapore | Consumer TechCore preventive health | East Ventures is a pioneering and leading sector-agnostic venture capital firm in Southeast Asia, backing over 300 portfolio companies from Seed to Growth stage. The firm has a dedicated healthcare-focused fund and a mission to foster a productive and healthy Southeast Asia, making it highly relevant to preventive health and longevity. | FORE)TokopediaTravelokaRuangguruShopBack, waresixXenditIDNSociolla | Avina Sugiarto, PartnerBatara Eto, Founding PartnerMelisa Irene, PartnerRoderick Purwana, Managing Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Echo Health Ventures | International longevity VCs | Seattle, United States | Core preventive health | Echo Health Ventures is a strategic venture firm that invests in companies transforming the healthcare system, focusing on digital health, healthcare services, and technology. They are relevant to preventive health through their investments in value-based care, chronic disease reversal, and platforms supporting holistic well-being. | Not captured | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Eight Roads | Adjacent longevity investors | London, United Kingdom | Core preventive health | Eight Roads is a global venture capital firm with over 50 years of investing experience, backing game-changing technology and healthcare companies to scale into global leaders. The firm's investment focus includes sectors directly relevant to preventive health, such as consumer health, healthcare IT, healthcare services, medtech, and pharma & therapeutics. | IcertisPaidyADAG) | Divesh Dhawan, Venture PartnerHarvinderjit Bhatia, Venture PartnerSanjay Aggarwal, Venture PartnerShirish Belapure, Venture Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Elaia | Adjacent longevity investors | Paris, France | Core preventive health | Elaia is a full-stack tech and deep tech investor based in Paris, France, that partners with ambitious entrepreneurs from inception to leadership. The firm focuses on disruptive technologies across various sectors, including digital health and biotech, making it relevant to preventive health and longevity. | MiraklAqemiaFlash TherapeuticsCriteoOrnikarAlice&BobSeqOne | Emma Aït Aoudia, Investor Relations Senior Associate | Startups / Founders (B2B)Professional & Institutional Investors | |
| Elaia VC | Adjacent longevity investors | Paris, France | Biotech | Elaia is a full-stack European venture capital firm based in Paris, France, investing in early-stage tech disruptors, particularly in deep tech, digital ventures, and biotech sectors. Its explicit focus on biotech, digital health, and digital life sciences, along with investments in AI-driven drug discovery and bioproduction technologies, makes it highly rel | AqemiaFlash TherapeuticsSeqOneMyCMiraklCriteo | Emma Aït Aoudia, Investor Relations Senior Associate | Startups / Founders (B2B)Professional & Institutional Investors | |
| Elefund | Adjacent longevity investors | Mountain View, United States | Consumer TechWellness Platforms | Elefund is a venture capital firm that invests in daring founders across various industries, including Fintech, AI, Enterprise, Aerospace, Travel, Health & Wellness, and Consumer Apps. The firm focuses on pre-seed, seed, and Series A stage companies, aiming to elevate the future through excellence and impact, with a notable interest in consumer tech and well | RobinhoodCartaEngine, simplifying business travel managementTalos, empowering institutions to trade digital assetsCalmFlo Health | Rasheen Smith, Venture PartnerNathan Rodland, General PartnerRoss Glasser, General PartnerSerik Kaldykulov, Founder/Managing Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Eleven | International longevity VCs | Sofia, Bulgaria | Core preventive health | Eleven is an early-stage venture capital fund based in Sofia, Bulgaria, investing in technology companies across Europe. The fund focuses on pre-seed and seed-stage investments in verticals including Fintech, Healthcare, Future of Work, and Sustainable Food, making it relevant to preventive health through its healthcare focus. | NitropackDronamicsEnhancv | Belizar Marinov, Investment PrincipalDaniel Tomov, PartnerIvaylo Simov, PartnerMartin Ouzounov, Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Elizabeth Street Ventures | Adjacent longevity investors | New York City, United States | Consumer TechWellness Platforms | Elizabeth Street Ventures is an early-stage investment firm based in New York City, United States, focused on the digital consumer sector. The firm invests in category-defining products and services within digital commerce and consumer fintech, including companies relevant to preventive health and wellness. | SimpliFedCurrentBilt RewardsContentsquareCornerUpFitz FramesSolarcore®Spice | Eric Brinker, VENTURE PARTNERLance Rosen, VENTURE PARTNERRachael Ulman, VENTURE PARTNERBen Sontheimer, CO-FOUNDER & GENERAL PARTNER | Startups / Founders (B2B)Professional & Institutional Investors | |
| Emerald Technology Ventures | Adjacent longevity investors | Zurich, Switzerland | Biotech | Emerald Technology Ventures is a global venture capital firm based in Zurich, Switzerland, dedicated to sustainable industrial innovation. The firm invests in startups that address global challenges related to climate change and sustainability, connecting them with corporations to accelerate innovation. | Tropic BiosciencesVYTALHydroPointINERATECNanoGrafFIDOFREDsense Technologies | Neil Cameron, Venture PartnerAnandhi Gokhale, Investment Director - EnergyChristoph Frei, Partner, Head of EnergyGina Domanig, Managing Partner, CEO | Startups / Founders (B2B)Professional & Institutional Investors | |
| EQT Life Sciences | Adjacent longevity investors | Amsterdam, Netherlands | Pharma/Drug discovery | EQT Life Sciences is a European venture capital firm, formerly known as LSP, focused on investing in innovative life sciences and healthcare companies globally. The firm provides capital and strategic support for the development of therapeutics, medical devices, diagnostics, and healthtech, aiming to address unmet medical needs and improve patient outcomes a | NeuraviEvommuneTubulisArtiosAM-PharmaMuna Therapeutics | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Equitage Ventures | Adjacent longevity investors | Denver, United States | Core preventive health | Equitage Ventures is a venture capital firm investing in early-stage companies that innovate solutions for older adults. It focuses on improving the quality of care and life across the aging journey, making it highly relevant to preventive health and longevity. | Coordinating and organizing America's fastest growing workforceNext | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Equity 38 | Adjacent longevity investors | Atlanta, United States | Core preventive health | Equity 38 is a private investment firm founded in 2015, specializing in tailored growth investments within the consumer sector. The firm focuses on building an enduring portfolio of leading consumer companies, including those in health and wellness, demonstrating relevance to preventive health. | Not captured | David Cox, Founder & Managing PartnerJames Walker, Strategic PartnerSean Hickey, Principal | Startups / Founders (B2B)Professional & Institutional Investors | |
| FCA Health Innovations | International longevity VCs | Nashville, United States | Core preventive health | FCA Venture Partners is a venture capital firm based in Nashville, United States, specializing in healthcare investments. The firm focuses on companies transforming healthcare through innovative technology and services, with a strong relevance to preventive health by improving patient care and reducing costs. | Azra AIthose relevant to preventive health and innovative care delivery | Andrew Bouldin, Managing PartnerAndy Lutz, PrincipalJohn Burch, PartnerNancy Allen, Partner, CFO | Startups / Founders (B2B)Professional & Institutional Investors | |
| Felix Capital | Adjacent longevity investors | London, United Kingdom | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care deliveryConsumer health & wellness | Felix Capital is a London-based venture capital firm that invests in companies at the intersection of technology and creativity, focusing on digital lifestyle, consumer brands, and enabling technologies. The firm's thematic approach to the evolution of the human experience includes investments in digital and consumer health, aligning with preventive health a | FarfetchMejuriMoonbugMiraklOatlyPeloton, yfoodEverdropPeppy | Frederic Court, Founder and Investor | Startups / Founders (B2B)Professional & Institutional Investors | |
| Female Founders Fund | Adjacent longevity investors | New York, United States | Core preventive healthWellness Platforms | Female Founders Fund is a seed-stage venture fund based in New York, United States, that exclusively invests in female-founded companies. The fund focuses on various sectors including e-commerce, media, platforms, advertising, web-enabled services, and notably, digital healthcare, with a strong emphasis on preventive care and women's health. | several relevant to health and wellnessMavenThrive GlobalOulaPrimaryShineAmini | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| FemHealth Ventures | International longevity VCs | New York City, United States | BiotechCore preventive healthPharma/Drug discovery | FemHealth Ventures is a venture capital firm based in New York City, United States, dedicated to investing in women's health innovations. The firm focuses on healthcare solutions addressing conditions that appear only in women, mostly in women, or differently in women, spanning early-stage investments in drugs, devices, diagnostics, and digital/AI technologi | Ossium HealthIantrekGT Medical Technologies10BeautyAlyssum TherapeuticsEvommuneMendaeraImperative Care | Sara Crown Star, Venture PartnerManeesha Ghiya, Managing PartnerStephan Oppenheimer, Private Equity InvestorStephanie Wang, Investor | Startups / Founders (B2B)Professional & Institutional Investors | |
| Firstminute Capital | Adjacent longevity investors | London, United Kingdom | Core preventive health | Firstminute Capital is a London-based seed fund that invests in early-stage technology companies across Europe, the UK, and occasionally the US. The firm is a generalist investor with deep expertise in AI and deeptech, and explicitly includes HealthTech as a key sector, demonstrating relevance to preventive health and longevity. | WayveMistralStoryblokn8nLindus HealthNablaVantisCodeWords | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| First Round Capital | Adjacent longevity investors | San Francisco, United States | Core preventive health | First Round Capital is a venture capital firm that invests exclusively at the earliest stages of company building, often when founders have only an initial idea. The firm focuses on technology companies across various sectors, including those relevant to preventive health, primarily at the seed and pre-seed stages. | NotionRobloxUberSquarePomelo CareVerkadaClayFlatiron Health | Knowlton Bennett, Chief of StaffMaddi Conlin, Chief of StaffLocke Luhnow, Associate Technical RecruiterMargarette Jung, Growth Marketing Director | Startups / Founders (B2B)Professional & Institutional Investors | |
| Fitt Capital | International longevity VCs | Pittsburgh, United States | Core preventive health | Fitt Capital is a venture fund that partners with mission-driven health, fitness, and wellness startups, investing in, advising, incubating, and acquiring early-stage companies. It focuses on increasing access to holistic wellness, high performance, and preventative care, aiming to help people live healthier lives. | AnyDistanceBalancedJunaJoonBird & BeFuture | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Five Seasons Ventures | Adjacent longevity investors | Paris, France | Biotech & aging scienceDigital health & AIClinics & care deliveryConsumer health & wellness | Five Seasons Ventures is a leading pan-European venture capital firm specializing in food-tech and agri-tech investments. The firm focuses on consumer brands that contribute to healthier, more efficient, and sustainable food systems, typically investing in Series A and B rounds. | Butternut BoxvlyKoRoTropic BiosciencesCortiliaHey HolyUntamed | Ivan Farneti, Managing PartnerMehdi Raza, Chief Financial OfficerNiccolo Manzoni, Managing PartnerSam Kaplan, Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Flagship Pioneering | Adjacent longevity investors | Cambridge, United States | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care delivery | Flagship Pioneering is a biotechnology company that invents and builds platform companies focused on transforming human health and sustainability. The firm's unique approach involves rigorous science and entrepreneurial innovation to create breakthrough ventures, with a significant emphasis on preemptive health and medicine. | ModernaIndigo AgricultureSana BiotechnologyEditas Medicine | Armen Mkrtchyan, Origination PartnerJacob Rubens, Origination PartnerKyle Chiang, Origination PartnerLovisa Afzelius, PhD, General Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Flare Capital Partners | International longevity VCs | Boston, United States | Core preventive health | Flare Capital Partners is a venture capital firm based in Boston, United States, specializing in healthcare technology investments. The firm partners with founders leveraging software, data, and AI to transform healthcare, focusing on improving patient outcomes, broadening care access, and lowering costs across Seed and Series A stages. | KnownwellAetionCore Qualified HealthAdniElektra HealthAspen RxHealth | BILL GEARY, Executive PartnerCHRIS HOCEVAR, Executive PartnerDAN GEBREMEDHIN, PartnerFlare Scholar Alumni, Executive Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Forbion | Adjacent longevity investors | Naarden, Netherlands | Pharma/Drug discovery | Forbion is a global venture capital firm dedicated to advancing groundbreaking biotech innovations for human health and sustainable solutions for planetary health. It invests across various stages, from pre-seed to growth, primarily in Europe and the US, with a focus on drug discovery and development. | CellCentricCoultreon BiopharmaAAVantgarde BioAmphista TherapeuticsVectorYargenx | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Forerunner Ventures | Adjacent longevity investors | San Francisco, United States | Core preventive health | Forerunner Ventures is an early-stage venture firm based in San Francisco, United States, that backs founders building companies around how people actually live, with a strong focus on consumer-focused companies leveraging AI. Its investments span various consumer categories, including health and wellness, making it relevant to preventive health and longevit | OuraHims & HersPrenuvoSuperpowerHeadway | Eurie Kim, PartnerFawzi Itani, PrincipalJason Bornstein, Partner, Head of ResearchKirsten Green, Founder, Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Foresite Capital | Adjacent longevity investors | San Francisco / Los Angeles / New York, United States | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care delivery | Foresite Capital is a multi-stage investment firm focused on healthcare and life sciences, leveraging biology and big data to transform the sector. The firm invests across all stages, from incubation to IPO and beyond, primarily within the United States. | 10x GenomicsAbdera TherapeuticsAlectorAlumis, Inc | Deepak Atri, Principal | Startups / Founders (B2B)Professional & Institutional Investors | |
| F-Prime Capital | Adjacent longevity investors | Cambridge, United States | Core preventive health | F-Prime Capital is a global venture capital firm with a heritage spanning four decades, investing in life sciences, technology, healthtech + services, and crypto. The firm's healthtech + services investments demonstrate a strong focus on improving patient care and healthcare delivery, including areas relevant to preventive health and longevity. | Devoted HealthGlobal fertility benefits providerVirtual eating disorder treatment providerOCD treatment provider | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| General Catalyst | Adjacent longevity investors | Cambridge, United States | Core preventive health | General Catalyst is a global investment and transformation company that partners with entrepreneurs to drive resilience and applied AI. The firm has a dedicated focus on transforming proactive, accessible healthcare through its "Health Assurance Transformation Company" platform, making it highly relevant to preventive health and longevity. | metabolic health and weight loss programsNewDaysLucisAirbnbStripeHubSpotKAYAK | Hemant Taneja, CEONeeraj Arora, CEO India, MENA & Managing Director | Startups / Founders (B2B)Professional & Institutional Investors | |
| Giant Leap | International longevity VCs | Melbourne, Australia | Core preventive health | Giant Leap is an Australian impact venture capital firm based in Melbourne, established in 2016 as Australia's first VC fund dedicated to impact investing. The firm backs mission-driven founders at Seed and Series A stages, focusing on companies that address pressing global problems across climate, health, and people. | Academy XiAmberAppliedChange FoodsEvrnu | Kylie Charlton, Venture PartnerPeter Cameron, Venture PartnerAdam Milgrom, PartnerRachel Yang, Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Giant Ventures | Adjacent longevity investors | London, United Kingdom | Consumer TechWellness Platforms | Giant Ventures is a purpose-driven venture capital firm based in London, United Kingdom, that invests in ambitious founders using technology to reshape civilization. The firm focuses on three core themes: climate, health, and inclusive capitalism, investing across Europe and the US from Pre-Seed to Growth stages. Its investment in health-focused companies li | DocclaCalmPano AIAgreenaFieldHaven EnergyBonusX | Cameron McLain, Co-Founder and Managing PartnerMadelene Larsson, PartnerMohadeseh Abdullahi, PartnerRob Hicks, Chief Financial Officer | Startups / Founders (B2B)Professional & Institutional Investors | |
| Gilde Healthcare | Adjacent longevity investors | Utrecht, Netherlands | Biotech | Gilde Healthcare is a specialized private investment firm managing over €3 billion across three fund strategies: Venture&Growth in Healthcare, Private Equity in Healthcare, and Private Equity in Climate Solutions. Its healthcare funds focus on investing in businesses that enable better care at lower cost, with a particular emphasis on healthtech and therapeu | WithingsInari MedicalAdcendoEndovascular EngineeringBig HealthPhysio CKI | David de Graaf, General Partner Climate SolutionsHein Ploegmakers, General Partner Climate SolutionsHugo de Bruin, General PartnerJanke Dittmer, General Partner Healthtech | Startups / Founders (B2B)Professional & Institutional Investors | |
| GingerBread Capital | Adjacent longevity investors | Menlo Park, United States | Core preventive health | GingerBread Capital is a family office investment firm that primarily invests in female founders and funds led by women and diverse teams. The firm focuses on early and growth-stage, technology-enabled businesses across various sectors, including healthcare and wellness, with a mission to close the funding gap for women-led ventures. | Incredible HealthAlaffia HealthNectirHopSkipDriveMaven HealthSpring HealthMidi HealthOula | Danielle Davis, Chief of StaffIta Ekpoudom, PartnerKatherine Rice, PartnerLinnea Conrad Roberts, Founder + CEO | Startups / Founders (B2B)Professional & Institutional Investors | |
| Hatzimemos / Libby | Adjacent longevity investors | New York City, United States | Consumer TechCore preventive health | H/L Ventures is a New York City-based venture capital firm and studio that invests in mission-driven, early-stage companies. They focus on businesses at the nexus of growth, impact, and diversity, with a strong emphasis on supporting companies that protect or promote people and the planet, including those in health and wellness. | SolsticeAndieNLXSorceroThermaAunt FlowMyavanaBlocPower | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| HBM Healthcare Investments | Adjacent longevity investors | Zug, Switzerland | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care deliveryConsumer health & wellness | HBM Healthcare Investments AG is a Swiss-listed investment company that specializes in building a globally diversified portfolio of private and public healthcare companies. It focuses on growth-stage biotechnology, medical technology, and diagnostic firms with products in advanced clinical development or already on the market. | Not captured | Not captured | Startups / Founders (B2B)Founded 2001 | |
| HCVC | Adjacent longevity investors | Paris, France | Biotech | HCVC is a venture capital firm based in Paris, France, that invests in early-stage hardtech companies from pre-seed to Series A across Europe and the US. The firm backs founders who are industrializing scientific and technological progress, with a focus on companies that leverage breakthrough technologies, including those in biotech and medtech, which can co | Fuse VectorsRemedee LabsDyna RoboticsChiral | CYRIL ABITEBOUL, Venture PartnerALEXANDRE FLAMANT, PartnerALEXIS HOUSSOU, Founder & Managing PartnerAYMERIK RENARD, General Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Headline | Adjacent longevity investors | San Francisco, United States | Consumer TechWellness Platforms | Headline is a global venture capital firm based in San Francisco, investing across various stages and sectors including software, AI, consumer, and fintech. The firm's portfolio includes companies relevant to consumer tech and wellness platforms, aligning with preventive health and longevity. | SonosFarfetchBumbleAcornsSemrushRaisinMistral AINatural Cycles | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Heal Capital | International longevity VCs | Berlin, Germany | Core preventive health | Heal Capital is a leading European HealthTech & AI VC firm based in Berlin, Germany, with over €200M AUM and 27 portfolio companies. It invests €1-5M from Pre-Seed to Series A across Europe, focusing on software, AI, and digitally-enabled care, and is relevant to preventive health through its emphasis on digital health solutions and portfolio companies addre | Apherisimproving mobility in Parkinson's patients | Christian Lautner, Founding Managing PartnerEckhardt Weber, Founding Managing Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| HealthCap | Adjacent longevity investors | Stockholm, Sweden | Pharma/Drug discovery | HealthCap is a European venture capital firm and company creator, established in 1996, that invests globally in life sciences. The firm focuses on breakthrough therapies for diseases with high unmet medical needs, aiming to significantly impact healthcare and society. | Actelion Holding LtdAdcendo ApSAerocrine ABAlgeta ASAAltimmune | Carl-Johan Dalsgaard, Venture Partner | MD PhDEugen Steiner, Venture Partner | MD PhDAlex Valcu, Partner | MScAnki Forsberg, Partner and Chairman | LLM MBA | Startups / Founders (B2B)Professional & Institutional Investors | |
| Healthier Capital | International longevity VCs | Menlo Park, United States | Core preventive health | Healthier Capital is a venture capital firm that partners with technology-powered healthcare innovators to advance healthier outcomes for all. The firm focuses on combining impactful innovation with significant value creation, primarily investing in early-stage companies at the intersection of healthcare and technology, with a strong relevance to preventive | Photon | Aman Mahajan, PARTNERAmir Dan Rubin, CEO AND FOUNDING MANAGING PARTNEREric Epstein, PARTNERGregor Kevrekian, PARTNER | Startups / Founders (B2B)Professional & Institutional Investors | |
| Healthspan Capital | International longevity VCs | El Cerrito, United States | BiotechCore preventive health | Healthspan Capital is an early-stage longevity venture capital firm that invests in biotechnology startups developing therapies to slow or reverse aging. The firm focuses on extending healthy human lifespan through rejuvenation biotechnology, making it highly relevant to preventive health. | Olden LabsImmuneAGE BioImmuneBridgeFauna Bio | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Healthy.Capital | International longevity VCs | Amsterdam, Netherlands | Core preventive health | Healthy.Capital is a Dutch venture fund based in Amsterdam that invests in pre-seed and seed-stage digital health solutions. The firm focuses on transforming healthcare through technology and digitalization, with a strong emphasis on preventive health and improving accessibility and affordability of care. | OpenUp GroupHomed-IQ | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Heartcore Capital | Adjacent longevity investors | Copenhagen, Denmark | BiotechPharma/Drug discovery | Heartcore Capital is a premier European venture capital firm that invests in early-stage technology companies from inception to Series A. The firm focuses on companies that re-enchant the world through technology, with a specific pillar dedicated to empowering people and promoting human well-being, making it relevant to preventive health. | AxanaWellness categoryTinkNeo4jTravelPerkPeakon | Fussing Nielsen, PartnerLindegaard Jepsen, PartnerMarie Sveinbjørnsson, Partner and Head of Capital FormationDalby Hillmann, Investor Relations Assistant | Startups / Founders (B2B)Professional & Institutional Investors | |
| Helsana HealthInvest | Adjacent longevity investors | Dübendorf, Switzerland | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care deliveryConsumer health & wellness | Helsana HealthInvest is the corporate venture capital (CVC) arm of the Helsana Group, Switzerland's leading health insurance provider.19 The organization invests in European digital health startups and venture funds that improve healthcare accessibility, efficiency, and quality, specifically within the DACH, Benelux, and Nordic regions.19 | Not captured | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Helvetic Trust – Longevity Investment Solutions | Longevity-focused investors & funds | Zurich, Switzerland | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care deliveryConsumer health & wellness | Helvetic Trust is an independent, owner-managed Swiss asset management and family office firm based in Zurich.33 The organization provides specialized "Longevity Investment Solutions" through its Private Equity and "Helvetic Ventures" divisions, targeting early-stage and growth-capital companies focused on the prolongation of life, biotechnology, and exponen | Not captured | CIO Aktien Schweiz, Senior PartnerStefan Unternährer, Geschäftsführender Senior Partner | Professional & Institutional InvestorsFounded 2024 | |
| Heran Partners | International longevity VCs | Antwerp, Belgium | Core preventive health | Heran Partners is a Belgium-based venture capital firm founded in 2019, specializing in early-stage MedTech and HealthTech companies across Europe. The firm focuses on disruptive innovation in healthcare and life sciences, aiming to generate scalable positive impact and financial returns by supporting technologies that improve diagnosis, patient monitoring, | Hypervision Surgical in the Diagnostic Equipment industryNuclivisionThirona | Katleen Vandersmissen, Managing PartnerRaf Roelands, PartnerWim Van Looveren, Finance Director | Startups / Founders (B2B)Professional & Institutional Investors | |
| Hiro Capital | Adjacent longevity investors | London, United Kingdom | Core preventive health | Hiro Capital is a founder-led European venture capital firm that invests in the future of humanity, focusing on technology sectors such as AI, spatial computing, games, sports tech, and longevity. The firm invests across Seed to Series C / Scale-Up stages, with a geographic footprint spanning the UK, Europe, and North America. | AMI LabsFrameplayIncredibuildPlayerDataZwift | Cherry Freeman, Founder & General PartnerLuke Alvarez, Founder & Managing General PartnerSir Ian Livingstone CBE, Founder & General PartnerSir Nick Clegg, General Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Hoxton Ventures | Adjacent longevity investors | London, United Kingdom | Core preventive health | Hoxton Ventures is a leading early-stage venture capital firm based in London, specializing in identifying and investing in innovative European technology startups. The firm focuses on building category-defining companies with a Silicon Valley mindset, encouraging them to tackle the US market early. | DeliverooDarktraceBabylon HealthKheiron MedicalMultiomic HealthPanakeia | Rishabh Kaul, Venture PartnerBryan Gartner, PartnerHussein Kanji, PartnerMidge Mazzier, Associate Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| HTGF (High-Tech Gründerfonds – Life Sciences & Chemistry) | Adjacent longevity investors | Bonn, Germany | Biotech | HTGF (High-Tech Gründerfonds) is a leading public-private venture capital firm based in Germany, specializing in pre-seed and seed investments in high-tech startups. Its Life Sciences & Chemistry team focuses on areas like biotech, pharma, oncology, and medtech, with a clear relevance to preventive health and longevity through its portfolio companies. | Argá Medtech | Startups / Founders (B2B)Professional & Institutional Investors | ||
| Human Capital | Adjacent longevity investors | San Francisco, United States | Core preventive health | Human Capital is a multi-stage venture capital firm based in San Francisco, United States, that invests in founders and teams building companies across critical industries. Their portfolio includes companies relevant to preventive health, such as those focused on chronic condition management and cancer care navigation. | LivongoJasper HealthTranscarentSnowflakeSpaceXAndurilBrexScale AI | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| H Venture Partners | Adjacent longevity investors | Cincinnati, United States | Biotech & aging scienceDigital health & AIClinics & care deliveryConsumer health & wellness | H Venture Partners is a next-generation venture fund and venture studio based in Cincinnati, Ohio, specializing in science-based consumer brands. They focus on companies that leverage microbiome technology to create products beneficial for human health and the planet, aligning with preventive health and longevity through their emphasis on early-stage nutriti | CerebellyAvalineFelixParsley HealthJoy | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Imaginary Ventures | Adjacent longevity investors | New York, United States | Biotech & aging scienceDigital health & AIClinics & care deliveryConsumer health & wellness | Imaginary Ventures is a New York-based venture capital firm that invests in generationally-defining consumer brands and the technology that powers them, primarily at the pre-seed, seed, and Series A stages. Their portfolio includes companies in health, wellness, beauty, and consumer packaged goods, making them relevant to preventive health and longevity. | GlossierSkimsReformationDaily HarvestKosasNecessaireCerebellySundays for Dogs | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Index Ventures (Healthcare) | Adjacent longevity investors | London, United Kingdom | Core preventive health | Index Ventures is a global venture capital firm that partners with entrepreneurs from Seed to IPO, investing across various technology sectors, including a significant focus on health tech. The firm is relevant to preventive health and longevity through its investments in companies that integrate clinical care, insurance, and prevention, and those developing | AlanBirdieNourishDeepScribeParallelFigmaWizRevolut | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| InHealth Ventures | International longevity VCs | London, United Kingdom | Core preventive health | InHealth Ventures is a London-based early-stage venture capital firm that invests in technology-enabled healthcare and life sciences companies. The fund focuses on re-engineering healthcare to improve patient access, clinical outcomes, and reduce costs, aligning with core preventive health principles. | AgamonAlyve HealthAxuallCION Cancer ClinicsClarify HealthDocentHealiosImvaria | Fiona Rooney, Founding PartnerIvan Bradbury, PartnerLavanya Bhamidipati, PartnerRichard Bradford, Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| INKEF Capital | Adjacent longevity investors | Amsterdam, Netherlands | Biotech | INKEF Capital is an early-stage, hands-on venture capital firm based in Amsterdam, Netherlands, primarily investing in the healthcare and technology sectors. The firm's focus on biotech, digital health, and corporate wellness platforms demonstrates its relevance to preventive health and longevity. | Rainier TherapeuticsTargED BiopharmaceuticalsSalvia BioElectronicsNMD PharmaUrban Sports ClubViCentraSimiBio | Startups / Founders (B2B)Professional & Institutional Investors | ||
| Inovo VC | Adjacent longevity investors | Warsaw, Poland | Core preventive health | Inovo VC is a seed-stage venture capital firm based in Warsaw, Poland, focused on ambitious founders in Central and Eastern Europe (CEE). The firm invests across multiple verticals, with a notable specialization in healthcare, making it relevant for preventive health and longevity research. | InfermedicaJutro MedicaluPacjentaPythagoras AI | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Inventages VC | International longevity VCs | Nassau, Bahamas | Biotech & aging scienceDigital health & AIClinics & care deliveryConsumer health & wellness | Inventages Venture Capital is a global investment firm, originally a corporate venture arm of Nestlé, focused on life sciences, consumer goods, healthcare, nutrition, and wellness. The firm invests across all stages, from seed to buyouts, with a strong emphasis on companies that contribute to health and wellbeing, making it highly relevant to preventive heal | Biosys HealthXOAM PharmaMSI Methylation SciencesOpsona | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Iris Ventures | Adjacent longevity investors | Barcelona, Spain | Core preventive health | Iris Ventures is a growth equity firm based in Barcelona, Spain, empowering a new generation of visionary consumer brands and tech-enabled solutions. The firm focuses on investments across beauty, health, wellness, family, and lifestyle sectors, with a strong relevance to preventive health and longevity. They invest in Seed, Series A, and later-stage rounds | OlisticBiomelHealfMaurtenNordic KnotsInnerskinGoddessArtemest | CELIA Bosch, PartnerFlorian Wojewodzki, PartnerMontse Suárez, Founder & Managing PartnerMarc Calzada, INVESTOR | Startups / Founders (B2B)Professional & Institutional Investors | |
| JamJar Investments | Adjacent longevity investors | London, United Kingdom | Digital health & AIClinics & care deliveryConsumer health & wellness | JamJar Investments is an early-stage European consumer venture capital firm founded by the creators of innocent drinks. The firm focuses on investing in and helping to build consumer brands across the UK and Europe, with a particular interest in products that resonate with consumers and have high exit potential. | RunnaDeliveroo, innocentWildTailsTony'sYepodaAheadHealf | Startups / Founders (B2B)Professional & Institutional Investors | ||
| Jeito Capital | International longevity VCs | Paris, France | Biotech & aging scienceDigital health & AIClinics & care delivery | Jeito Capital is a leading global investment company and the largest fully independent European fund dedicated to Biopharma. It focuses on financing and accelerating cutting-edge medical innovation in biopharma and innovative medical companies, particularly in areas of high unmet medical need. | Neogene TherapeuticsPulmocideQuell TherapeuticsNMD PharmaCatalYm | Julien Elric, Senior PrincipalKsenija Pavletic, General Partner & Chief Commercial OfficerMaya Chkaiban, PrincipalMehdi Ainouche, Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Joyance Partners | Adjacent longevity investors | San Francisco, United States | Core preventive health | Joyance Partners is a venture capital firm investing in companies that use science and technology to cultivate joy and improve lives across North America, Europe, and Asia. They focus on health and consumer sectors, investing from pre-seed to Series A stages, with a strong relevance to preventive health and longevity through their focus on personal health, f | RUBYBIO HEALTHCARELark HealthNimbleElectric EraExponent BeautyAlba HealthAltr BeautyBubble | Alexander Stoeckel, Managing PartnerAlice Ko, Investment PartnerAndrew Nealon, Partner & CTOBradley Welch, Managing Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Kaiser Permanente Ventures | International longevity VCs | Oakland, United States | Core preventive health | Kaiser Permanente Ventures is a corporate venture capital firm and a national leader in strategic healthcare venture investing, aiming to advance healthcare innovation. The firm focuses on solutions that provide clear value for patients, providers, healthcare delivery systems, and the larger community, aligning with core preventive health initiatives. They i | AbridgeVesta HealthcareOmada HealthDexCareNOCDHealth Catalyst | Alexandra Shandiz, PrincipalGina Crisosto, Chief of StaffJin Zhang, PrincipalAmy Belt Raimundo, Vice President & Managing Director | Startups / Founders (B2B)Professional & Institutional Investors | |
| Kapor Capital | Adjacent longevity investors | Oakland, United States | Core preventive health | Kapor Capital is an Oakland-based venture capital firm that invests in early-stage startups (Pre-seed, Seed, Series A) across the United States. The firm focuses on impact investing, specifically supporting companies that close gaps of access, opportunity, and outcomes for low-income communities and underrepresented communities of color, including those in t | Not captured | Brandon Boros, Venture PartnerBatul Joffrey, PartnerBrian Dixon, Managing PartnerHilliary Turnipseed, Head of Platform | Startups / Founders (B2B)Professional & Institutional Investors | |
| Karista VC | Adjacent longevity investors | Paris, France | Core preventive health | Karista is a European early-stage venture capital firm, founded in 2001, investing in Health, Digital, DeepTech, and NewSpace sectors. The firm focuses on supporting ambitious companies from Seed to Series B+ stages, primarily across Europe with a strong emphasis on France, DACH, and Benelux. Karista's investments in Digital Health, including patient monitor | DeemeaWaiv | Agathe Biard, Chief Compliance OfficerBaudouin Hue, PartnerBenjamin Zerbib, PartnerCatherine Boule, Managing Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Kaya Ventures | Adjacent longevity investors | Los Angeles, United States | Core preventive healthWellness Platforms | Kaya Ventures is an early-stage venture capital firm based in Los Angeles, California, focused on powering the next wave of health innovation. The firm invests in companies redefining health and wellness, particularly within underserved markets, with a strong emphasis on preventive health, women's health, longevity, and digital health. | AOA Dx | Madeline Darcy, Managing Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Khosla Ventures | Adjacent longevity investors | Menlo Park, United States | BiotechCore preventive health | Khosla Ventures is a prominent American venture capital firm that invests in bold, early, and impactful ventures across various stages, from seed to growth equity. The firm has a significant focus on healthcare, including core preventive health, digital health, biotech, and longevity, aiming to support companies that extend healthspan and address age-related | Guardant HealthSword HealthAliveCorRejuvenation TechnologiesLoyalRubedoR1 RCMBold | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Kindred Capital | Adjacent longevity investors | London, United Kingdom | BiotechCore preventive health | Kindred Capital is a London-based venture capital firm established in 2015, specializing in pre-seed and seed stage investments across the UK, Europe, and Israel. The firm operates on an "equitable venture" model, where every founder it backs becomes a co-owner of the fund. Kindred Capital invests in mission-driven technology companies, including those in bi | RobCoCradleLottieFivePaddleGravity Sketch | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Kizoo Technology Capital | Adjacent longevity investors | Karlsruhe, Germany | Biotech | Kizoo Technology Capital is a venture capital firm based in Karlsruhe, Germany, primarily investing in rejuvenation biotech and, historically, Internet & SaaS. It focuses on technologies that aim to prevent and reverse the diseases of aging by addressing their root causes, thereby extending healthy lifespans. | Reservoir NeuroscienceCyclarityElastrinRevel PharmaceuticalsCellvieUnderdog PharmaceuticalsMoglingBio | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Korify Capital | Longevity-focused investors & funds | Basel, Switzerland | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care deliveryConsumer health & wellness | Korify Capital is a Basel-based venture capital firm focused on breakthrough technologies in longevity and mental health.40 It is the specialized investment arm of the Swiss family office Infinitas Capital.18 | Not captured | Davide Ottolini, Founding PartnerRobin Lauber, Founding Partner | Professional & Institutional InvestorsFamily OfficesWellness-oriented ConsumersFounded 2021 | |
| Krillion | Adjacent longevity investors | Miami, United States | Core preventive health | Krillion Ventures is a Miami-based venture capital fund that provides Seed and Series A stage funding to tech-enabled companies. The fund actively invests in early-stage technology companies solving problems in healthcare, financial services, and real estate, with a specific focus on HealthTech, making it relevant to preventive health and longevity. | CohealoGT Metabolic SolutionsHeruInner CosmosInsightecLogicInkMemicWesper | Jeffrey Miller, Managing Partner -->Melissa Krinzman, Managing Partner --> | Startups / Founders (B2B)Professional & Institutional Investors | |
| Kurma Partners | International longevity VCs | Paris, France | BiotechPharma/Drug discovery | Kurma Partners is a leading European venture capital firm based in Paris, France, specializing in healthcare and biotechnology. The firm invests at various stages, from company creation to capital expansion, focusing on transforming disruptive scientific discoveries into cutting-edge medical solutions for diseases with high unmet medical needs. | PharvarisImcheck TherapeuticsStilla TechnologiesNuevocorAdociaLaigo Bio | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| L Catterton | Adjacent longevity investors | Greenwich, United States | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care deliveryConsumer health & wellness | L Catterton is a leading global consumer-focused private equity firm with approximately $37 billion of equity capital under management, specializing in building iconic and enduring consumer brands across various segments of the consumer industry. The firm invests in companies that align with evolving consumer preferences, including those in health, wellness, | ThorneVitamin PacksTulaNutrafolGood CultureSquared CirclesWellness Pet CompanyPeloton | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Leaps by Bayer | International longevity VCs | Berlin, Germany | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care deliveryConsumer health & wellness | Leaps by Bayer is the corporate venture capital arm of Bayer AG, established in 2015, focusing on strategic investments in life sciences. It targets paradigm-shifting breakthroughs in health and agriculture to address major global challenges, including those relevant to preventive health and longevity. | Recursion PharmaceuticalsHumaSenti BiosciencesWellTheoryPairwiseAda Health | Derek Norman, Vice PresidentFabio Pucci, InvestorLucio Iannone, Vice PresidentNaveen Krishnan, Investor | Startups / Founders (B2B)Professional & Institutional Investors | |
| Lerer Hippeau | Adjacent longevity investors | New York City, United States | Core preventive healthWellness Platforms | Lerer Hippeau is an early-stage venture capital fund based in New York City, specializing in pre-seed and seed investments. The firm is a generalist investor with a focus on innovative technology startups, including those in the healthcare and wellness & longevity sectors. | HeartbeatHungryrootK HealthOscarProseTopicalsZiplineGuideline | Ron Zori, Venture PartnerAndrea Hippeau, PartnerBen Lerer, Managing PartnerEric Hippeau, Managing Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| LifeArc Ventures | Adjacent longevity investors | London, United Kingdom | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care delivery | LifeArc Ventures is a venture fund that invests in early-stage, science-led life science companies, focusing on therapeutics, HealthTech, and medical devices. As part of the medical research charity LifeArc, it aims to generate financial returns to reinvest in LifeArc's charitable goals while positively impacting patients' lives. | MC SciencesGlycoEraFluid BiomedTIkarovec | Clare Terlouw, Managing PartnerSohaib Mir, Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Lightstone Ventures | Adjacent longevity investors | Menlo Park, United States | Biotech | Lightstone Ventures is a venture capital firm focused on early-stage investments in the biotech and medtech sectors. The firm aims to translate novel scientific breakthroughs into clinically and commercially meaningful therapies and technologies to transform patients' lives. | Nimbus TherapeuticsCala HealthShoulder InnovationsReprieve CardiovascularCatamaran Bio | Mike Carusi, Managing Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| LionBird Ventures | International longevity VCs | Tel Aviv, Israel | BiotechCore preventive health | LionBird Ventures is a venture capital firm based in Tel Aviv, Israel, focused on investing in early-stage companies that are leveraging technology to transform healthcare. The firm provides pre-scale capital and assistance to teams aiming to fix healthcare, with a clear relevance to preventive health and biotech innovations. | BluespineRuby HealthPhaseV | Itschak Friedman, Venture PartnerRobert Lord, Venture PartnerChaim Friedman, PartnerEd Michael, Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Listen Ventures | Adjacent longevity investors | Chicago, United States | Wellness Platforms | Listen Ventures is a Chicago-based venture capital firm founded in 2010, specializing in early-stage consumer brands. The firm partners with entrepreneurs who are building disruptive brands at the tipping point of behavior shifts, with a focus on areas including preventive health and wellness. | BlackBuffaloDameGood BacteriaRise GardensFactorKiwi CoDelta BeverageCafeteria | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| LocalGlobe | Adjacent longevity investors | London, United Kingdom | BiotechCore preventive health | LocalGlobe is a London-based venture capital firm that specializes in pre-seed and seed investments, primarily across the UK and Europe. The firm has a broad sector focus, including significant interest and investments in healthtech and biotech, aiming to be a long-term partner for founders. It actively seeks opportunities at the intersection of life science | CoMindModulight BiotherapeuticsHuman HealthHeidiEchoAccuRxHertility HealthVira Health | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Longevity Fund by Clinique La Prairie | Longevity-focused investors & funds | Clarens, Switzerland | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care deliveryConsumer health & wellness | The Longevity Fund by Clinique La Prairie is a specialized sub-fund of the EFG Alternative Investment SICAV-RAIF that invests in science-based advancements in biotechnology and preventive medicine. Focused on scaling longevity innovations, the fund targets ventures across four clinical pillars: Medical, Nutrition, Wellbeing, and Movement, leveraging nearly a | Not captured | Not captured | Startups / Founders (B2B)Professional & Institutional InvestorsFounded 2025 | |
| Longevitytech.fund | International longevity VCs | Boca Raton, United States | Biotech | Longevitytech.fund is a venture capital firm dedicated to supporting innovations that extend human lifespan and improve healthspan. It focuses on early-stage investments (pre-seed to Series A) in the longevity, biotech, and healthcare sectors, with a primary geographic focus on the United States. | Juvena TherapeuticsMitoRx TherapeuticsNOVOSMaxWell BiosciencesOccuityRepair BiotechnologiesGenflow BiosciencesRemedium Bio | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Longevity Venture Partners | International longevity VCs | Baltimore, United States | Biotech | Longevity Venture Partners is an early-stage venture capital firm based in Baltimore, Maryland, dedicated to investing in the Silvertech, Healthcare, and Wellness sectors. The firm focuses on emerging technologies and opportunities that improve the quality and longevity of the older and aging population. | CustoMED | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Longevity Vision Fund | International longevity VCs | New York City, United States | BiotechCore preventive health | Longevity Vision Fund is a New York City-based venture capital firm that invests in technologies and companies aiming to extend healthy human lifespans. The fund focuses on longevity breakthroughs, particularly in preventive health, biotech, and AI in healthcare, across Seed to Series C stages. | 4D Molecular TherapeuticsFreenome HealthSenda BiosciencesTessera TherapeuticsEko HealthIn Silico MedicineBiolinqLyGenesis | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| LongGame VC | International longevity VCs | London, United Kingdom | BiotechCore preventive health | LongGame VC is a London-based venture capital firm investing in pre-seed and seed-stage longevity biotech companies. The firm focuses on funding technologies that aim to radically increase healthy human lifespan by targeting the root causes of aging, making it highly relevant to preventive health and longevity research. | Cirrus TherapeuticsRepair BiotechnologiesImmuneBridge | Manish Chamoli, Co-Managing Partner and Chief Scientific OfficerSebastian Brunemeier, Co-Managing PartnerWill Harborne, GP & Chief Investment OfficerChloe Northcott, Head of Operations | Startups / Founders (B2B)Professional & Institutional Investors | |
| Looking Glass | Adjacent longevity investors | New York, United States | Core preventive health | Looking Glass Capital is an early-stage venture capital firm based in New York, investing in mission-driven founders building software and software-driven companies. The firm focuses on themes of health, climate, and empowerment, making it relevant to preventive health through its health-focused investments. | not presented as current Looking Glass Capital portfolio companies | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| LSVP | Adjacent longevity investors | San Francisco, United States | BiotechCore preventive healthPharma/Drug discovery | LSVP (Lightspeed Venture Partners) is a multi-stage venture capital firm that invests in disruptive innovations across various sectors, including enterprise, consumer, fintech, healthcare, and AI. The firm is relevant to preventive health through its investments in companies focused on early detection and proactive well-being. | AnthropicThoughtSpotAlloyNeko HealthWizUltima GenomicsRubrikNavan | Aaron Frank, Partner // USAlexander Schmitt, Partner // EuropeAmber Yang, Partner // USAnoushka Vaswani, Partner // US | Startups / Founders (B2B)Professional & Institutional Investors | |
| Ludis Capital | Adjacent longevity investors | Los Angeles, United States | Sports | Ludis Capital is an early-stage venture capital firm that invests at the intersection of sports, technology, and media & entertainment. Based in Los Angeles, the firm targets pre-seed, seed, and seed-plus stage companies globally, with a focus on innovations that can also broadly impact human society and well-being. | 3ICEOvertimeBlockassetGET)YBVRPumpJack DataworksSPORT BUFFPreediction | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Lunar Ventures | Adjacent longevity investors | Berlin, Germany | BiotechCore preventive healthPharma/Drug discovery | Lunar Ventures is a Berlin-based venture capital firm that invests in deep tech founders with global ambitions, focusing on pre-seed and seed stage companies. Their investment areas include Tech Bio and Science + ML, making them relevant to the preventive health and longevity sectors through advancements in biotech and drug discovery. | ZamadeepsetOteraElectric SQLMoleculeAxiom TherapeuticsSemiqon | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Lux Capital | Adjacent longevity investors | New York, United States | Biotech | Lux Capital is a venture capital firm based in New York, United States, focused on investing in emerging science and technology companies across various stages. The firm champions companies that aim to turn "sci-fi into sci-fact" and explicitly includes "Advancing Human Health" as a key mission, making it relevant to preventive health and longevity. | Eikon TherapeuticsAndurilSakana AIHugging Face, progressing science and knowledgeRunway, enabling human creativity and free expressionApplied Intuition, increasing productivity and efficiencyA-Alpha Bio3D Robotics | Startups / Founders (B2B)Professional & Institutional Investors | ||
| Magma Partners | Adjacent longevity investors | Santiago, Chile | Core preventive health | Magma Partners is a venture capital firm that specializes in identifying, investing in, and supporting early-stage technology startups across Latin America, from pre-seed to Series A. The firm demonstrates relevance to preventive health through its investment in companies like Corpus AI, which focuses on predicting chronic disease risk. | NuvocargoBillpocketKushkiAlboCorpus AI | Codie Sanchez, Venture PartnerDiego Philippi, Venture Partner - ChileEugenio Perea, Venture PartnerNabil Meralli, Venture Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Magnify Ventures | Adjacent longevity investors | Los Angeles, United States | Core preventive health | Magnify Ventures is an early-stage venture capital fund based in Los Angeles, United States, that invests in technology companies transforming life, work, and care for modern families. The firm's focus on the care economy, including aging innovation and solutions from childbirth to end-of-life, makes it relevant to preventive health and longevity. | CocoonElement3 HealthMiloMiSaludPapaSeven StarlingTill Financial | Joanna Drake, Co-Founder & Managing PartnerJulie Wroblewski, Co-Founder & Managing PartnerMarie Drez, Chief Financial Officer | Startups / Founders (B2B)Professional & Institutional Investors | |
| Market One Capital | Adjacent longevity investors | Luxembourg, Luxembourg | Core preventive healthWellness Platforms | Market One Capital is a European early-stage venture capital firm that invests in pre-seed and seed stage startups, primarily focusing on marketplaces and network effects platforms across Europe. The firm has a stated interest in HealthTech and has invested in companies that facilitate access to healthcare services, aligning with preventive health and wellne | several notable onesDocPlannerNavio LogisticsVINRRizon | Startups / Founders (B2B)Professional & Institutional Investors | ||
| Maveron | Adjacent longevity investors | Seattle, United States | Digital health & AIClinics & care deliveryConsumer health & wellness | Maveron is a consumer-centric venture capital firm, founded in 1998, that focuses on early-stage (Seed and Series A) investments in companies transforming how people live, work, learn, play, eat, and stay well. The firm is relevant to preventive health through its investments in mental health and chronic condition management platforms. | Two ChairsThirty MadisonAllbirdsLoveveryRec RoomSage | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Maximon | Venture Capital / Venture Builders | Zug, Switzerland | Core preventive health | Maximon is a Swiss longevity company builder that empowers entrepreneurs to create science-based companies focused on healthy aging and rejuvenation solutions. It invests in pre-seed and seed-stage companies across the longevity value chain, with a strong emphasis on preventive health. | AVEA LifeAYUN | Caroline Wagner, Founding PartnerTobias Reichmuth, Founding PartnerCédric Diego Vollmar, Head of Finance | Startups / Founders (B2B)Professional & Institutional InvestorsFounded 2021 | |
| Mckesson VC | International longevity VCs | San Francisco, United States | Digital health & AIClinics & care delivery | McKesson Ventures is the corporate venture capital arm of McKesson, focused on investing in healthcare innovators to build and scale health startups. The fund targets companies that improve the quality and efficiency of healthcare, with a particular emphasis on health information technology and technology-enabled services. | Midi Health | Carrie Hurwitz Williams, Partner, VentureMichelle Snyder, Partner, VentureJennifer Carter, Partner & VP Venture OperationsPeter Lafer, Partner, Head of Growth Equity | Startups / Founders (B2B)Professional & Institutional Investors | |
| Medicxi | International longevity VCs | London, United Kingdom | BiotechPharma/Drug discovery | Medicxi is a European investment firm focused on the life sciences sector, established in 2016 by the former Index Ventures life sciences team. The firm invests across the full drug development continuum, from discovery stage to pivotal studies and registration, with a mission to bring novel therapies to patients in need. | Centessa PharmaceuticalsRAPT TherapeuticsAldena TherapeuticsGraegis PharmaceuticalsGranular TherapeuticsOttimo PharmaVicebioAltesa BioSciences | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Medmountain Ventures | International longevity VCs | Salt Lake City, United States | BiotechCore preventive health | Medmountain Ventures is an early-stage venture capital firm based in Salt Lake City, Utah, investing in companies shaping the future of health and wellness. The firm focuses on biotech, digital health, preventive care, and longevity, making it highly relevant to the preventive health and longevity sectors. | publicly listed or verifiable across the available sources | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Mercia Ventures | Adjacent longevity investors | Henley-in-Arden, United Kingdom | BiotechPharma/Drug discovery | Mercia Ventures is a prominent UK venture capital firm that invests in ambitious founders at Seed, Series A, and beyond, focusing on high-growth businesses across sectors including AI & Software, Consumer, Deep Tech, and Life Sciences. Their investment in Life Sciences, particularly in digital biology and drug discovery, positions them as relevant to prevent | Wobble GenomicsDxCoverTurbineOptellumKuanoAlesi SurgicalBen | Graham Davies, Fund PrincipalAdam Lovell, InvestorAdam Watts, InvestorAlex Gwyther, Investor | Startups / Founders (B2B)Professional & Institutional Investors | |
| Meridian Street Capital | International longevity VCs | New York, United States | Core preventive health | Meridian Street Capital is an early-stage venture capital firm that invests exclusively at the intersection of healthcare and technology. The firm supports founders from pre-seed through Series A stages, aiming to engineer the future of healthcare. | 1upHealthIsaac HealthJona HealthOunce of CarePreemptive AIRulaSafe Ride HealthTreat My OCD | Startups / Founders (B2B)Professional & Institutional Investors | ||
| Midnight Ventures | Adjacent longevity investors | Austin, United States | Core preventive health | Midnight Ventures is an Austin-based venture capital firm focused on investing in and scaling the next generation of iconic consumer brands. The firm primarily targets early-stage consumer packaged goods (CPG) and wellness products, providing both capital and extensive go-to-market expertise. | OlipopRecessMagic MindJolieHappy DadSeshHumanaut Health | Aaron Henderson, Partner, RetailAL SPRINGER, Partner, RetailALEX BODNEY, Co-Founder, PartnerBEN DAVIS, Partner, Deal Structure | Startups / Founders (B2B)Professional & Institutional Investors | |
| Mindspring Capital | Adjacent longevity investors | Newport Beach, United States | Sports | Mindspring Capital is a globally oriented, early-stage venture capital firm that invests in technology ventures within the sports industry. The firm focuses on pre-seed, seed, and Series A rounds, aiming to fuel the future of sports through strategic and financial support. | HorizmSatisfi LabsCredenzaMinute SpoteamPumpjack Dataworks | Daniel Bernard, Venture PartnerCraig Thompson, Managing PartnerDavid Hackett, General PartnerSandy Khaund, Managing Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| MMC Ventures | Adjacent longevity investors | London, United Kingdom | BiotechCore preventive health | MMC Ventures is a London-based venture capital fund that invests in early-stage, high-growth technology companies across Europe. The firm focuses on Seed and Series A rounds, with a strategic emphasis on enterprise AI, fintech, data-driven health, data infrastructure, and cloud technologies, making it relevant to preventive health through its data-driven hea | YuLifeSynthesiaSignal AIAlbatross AICopperRed SiftTracebit | Startups / Founders (B2B)Professional & Institutional Investors | ||
| Molten Ventures | Adjacent longevity investors | London, United Kingdom | BiotechCore preventive healthWellness Platforms | Molten Ventures, formerly Draper Esprit, is a British venture capital firm that invests in high-growth technology companies across Europe. They back ambitious founders from Series A and beyond, with a focus on disruptive sectors including digital health and wellness, making them relevant to preventive health and longevity research. | RevolutAircallLedgerTrustpilotWiseUiPathThought Machine | Alan Duncan, Venture PartnerBrian Caulfield, Venture PartnerDavid Cummings, Venture PartnerAndrew Zimmermann, Chief Financial Officer | Startups / Founders (B2B)Professional & Institutional Investors | |
| Monogram Capital Partners | Adjacent longevity investors | Beverly Hills, United States | Diagnostics & biomarkersDigital health & AIClinics & care deliveryConsumer health & wellness | Monogram Capital Partners is a private equity investment firm founded in 2014, specializing in consumer and retail companies. The firm provides capital, strategic guidance, and operational expertise to help promising brands become category leaders, with a focus on growth and lower middle-market businesses. Its investment in consumer packaged goods (CPG) comp | Beach House GroupCountry ArcherOLIPOPKidfreshDig InnEllenos yogurt | JARED STEIN, Co-Founder & PartnerKRISTINA LEE, PrincipalMICHAEL LI, PrincipalOLIVER NORDLINGER, Co-Founder & Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Morpheus Ventures | Adjacent longevity investors | Los Angeles, United States | BiotechCore preventive health | Morpheus Ventures is a Los Angeles-headquartered venture capital fund that invests in early-stage, technology-driven companies across the United States. The firm is relevant to preventive health through its investments in companies simplifying health insurance and promoting healthier, longer lives. | Sidecar HealthLive healthier, happier and longerHouseCanarySafetyCultureLet's Do ThisVicarious | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| MSA Capital | Adjacent longevity investors | Beijing, China | BiotechPharma/Drug discovery | MSA Capital is a global investment firm founded in 2014, managing over USD 2 billion in private venture and growth assets. The firm focuses on highly innovative and disruptive companies in biotechnology and enterprise-facing core technology, with a significant emphasis on the healthcare and longevity sectors. | LiveForeverHealthBeijing Genomic InstituteYidu CloudNIO)Meituan | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Muse Capital | Adjacent longevity investors | Santa Monica, United States | Core preventive health | Muse Capital is an early-stage venture fund based in Santa Monica, California, investing in consumer technology with a focus on underserved markets. The firm's investment thesis centers on the future of how we care, play, and live, with a significant emphasis on women's health and preventive solutions. | Midi HealthBeSoundConceivable Life SciencesEli HealthCofertilityMahmeeMavida HealthBeekeeper’s Naturals | Elizabeth Gill, Venture PartnerAssia-Grazioli Venier, Founding PartnerMaria De Santis, PrincipalRachel Springate, Founding Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Mustard Seedmaze MSM | Adjacent longevity investors | Lisboa, Portugal | Core preventive health | Mustard Seedmaze (MSM) is an impact VC fund based in Lisboa, Portugal, investing in fast-growing European ventures that address social and environmental challenges. The fund focuses on businesses where impact and financial returns are mutually reinforcing, supporting companies from pre-seed to Series A, including those relevant to preventive health. | BiorceYurtleSamara | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| M Ventures | International longevity VCs | Amsterdam, Netherlands | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care delivery | M Ventures is the strategic corporate venture capital fund of Merck KGaA, Darmstadt, Germany, investing globally in biotechnology and technology sectors. It focuses on healthcare drug development, life science tools, electronics, and frontier technology & sustainability, aiming to support innovations that improve human well-being. | ActitheraFuture FertilityiOncturaStorm Therapeutics | Jon Herlocker, CEO, Christy Prada, CEOHakan Goker, Managing Director | Startups / Founders (B2B)Professional & Institutional Investors | |
| MVM Partners | International longevity VCs | Boston, United States | Biotech | MVM Partners is a global life sciences private equity firm that invests in innovative, high-growth healthcare companies. The firm focuses on businesses transforming healthcare delivery through higher quality, cost-effective care and addressing significant unmet medical needs across various sectors. | ProVerumNeurent Medical | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| NaturalX Health Ventures | International longevity VCs | Karlsruhe, Germany | Core preventive health | NaturalX Health Ventures is a €100 million venture capital fund backed by Schwabe Group, focusing on consumer health companies at the intersection of wellness and medicine. The fund primarily targets Series A and Series B investments in Europe, with a strong emphasis on proactive health, including prevention and longevity. | Jutro MedicalFunction HealthHiloKyan HealthFlow NeuroscienceMeela Healthmybacs | Startups / Founders (B2B)Professional & Institutional Investors | ||
| Nestlé Health Science | Adjacent longevity investors | Vevey, Switzerland | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care deliveryConsumer health & wellness | Nestlé Health Science is a globally integrated health and nutrition organization that operates at the intersection of consumer goods and pharmaceutical therapies to address chronic conditions and promote healthy aging. Through a portfolio of medical nutrition, active lifestyle products, and clinical-stage pharmaceuticals, the company leverages science-based | Not captured | Not captured | General PopulationAdults 40+SeniorsFounded 2011 | |
| New Fare Partners | International longevity VCs | New York, United States | Digital health & AIClinics & care deliveryConsumer health & wellness | New Fare Partners is a female-led venture capital firm based in New York, United States, specializing in early-stage investments within the food and beverage sector. The firm focuses on innovative consumer brands, supply chain technologies, and modern retail marketplaces that align with evolving consumer demands for healthier and more sustainable food option | Siete Family FoodsOatlyMiyoko's CreameryActual VeggiesMid-Day SquaresNara OrganicsLucille | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Newfund Capital | Adjacent longevity investors | Paris, France | Core preventive healthPharma/Drug discoveryWellness Platforms | Newfund Capital is an entrepreneurial VC firm based in Paris and Silicon Valley, dedicated to financing seed-stage startups that are driving global change. The firm invests in companies across various sectors, including a significant focus on preventive health, wellness platforms, and pharma/drug discovery, aligning with its philosophy of investing in what i | AI StrokeDux HealthcareDiagnolyNureaSoihtu DTxTin CanOne ZymeShareID | Garin Pitzini, Chief Financial & Sustainability OfficerSalim Hassad, Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Nextcoast ventures | Adjacent longevity investors | Austin, United States | Core preventive health | Next Coast Ventures is an Austin, Texas-based venture capital firm founded in 2015, focused on investing in early-stage, high-growth companies located in "Next Coast" markets outside of traditional coastal hubs. The firm demonstrates relevance to preventive health through investments in digital health, at-home diagnostics, and cognitive health solutions. | Everly HealthAlzheimer'sBrainCheck | Kaitlyn DeBernardo, Partner, COO & Head of PlatformMike Smerklo, Co-Founder and Managing DirectorThomas Ball, Co-Founder and Managing Director | Startups / Founders (B2B)Professional & Institutional Investors | |
| NGEN Partners | Adjacent longevity investors | New York, United States | Biotech & aging scienceDigital health & AIClinics & care deliveryConsumer health & wellness | NGEN Partners is a New York-based venture and growth equity firm founded in 2001, investing in innovative B2B and B2C companies that offer healthier, smarter, and more efficient solutions. The firm focuses on businesses that capitalize on next-generation consumer behavior and contribute to a healthier, smarter, and cleaner world, making it relevant to preven | Bare SnacksBrightFarmsCoraEnzymedicaRevolution FoodsZevia | PETER GRUBSTEIN, Managing Director & FounderSHAY MURPHY, PartnerROSEMARY RIPLEY, Managing Director | Startups / Founders (B2B)Professional & Institutional Investors | |
| Nina Capital | International longevity VCs | Barcelona, Spain | BiotechCore preventive healthPharma/Drug discovery | Nina Capital is a specialized venture capital firm based in Barcelona, Spain, investing exclusively in need-driven health technology companies. The firm focuses on pre-seed, seed, and Series A stages, supporting innovations that leverage information technology, data, and computing to transform healthcare globally. Its investment thesis is informed by the Sta | RiviaSonar Mental HealthNoah LabsUltromics | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| NLC | International longevity VCs | Amsterdam, Netherlands | Biotech | NLC Health Ventures is a world-leading healthtech venture builder and investment fund based in Amsterdam, Netherlands. It focuses on finding, building, and scaling transformative health innovations from pre-seed to Series A stages, aiming to transform patient lives by bridging the gap between scientific discoveries and the market. | AmotioSigilla MedicalExolvo BiosciencesPEP HealthHaermonics | Augusta Poteliunaite, Cluster Talent Partner & RecruiterBert-Arjan Millenaar, Founder & CEOAntoinette van Lier, Supervisory BoardDirk Pekelharing, Supervisory Board | Startups / Founders (B2B)Professional & Institutional Investors | |
| Noetic Fund | International longevity VCs | Toronto, Canada | BiotechCore preventive healthPharma/Drug discovery | Noetic Fund is a venture firm investing in early-stage technologies that address mental health and wellbeing, with a global outlook. Their diversified strategy spans novel drug therapeutics, psychedelic-assisted therapies, digital health, medical devices, and wearables, emphasizing early intervention and prevention for human flourishing. | MindMedField Trip Health & WellnessAwakn Life SciencesCybinNuminus Wellness, atai Life SciencesSmall PharmaBraxia Scientific | Sa'ad Shah, Managing Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Norrsken VC | Adjacent longevity investors | Stockholm, Sweden | Core preventive health | Norrsken VC is Europe's leading early-stage impact investor, backing companies that tackle global challenges while building massive businesses. The firm is relevant to preventive health through investments in digital health solutions for chronic conditions and advancements in drug development. | OvivaOnepotElsa Science | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Novartis Venture Fund | International longevity VCs | Basel, Switzerland | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care delivery | Novartis Venture Fund is a corporate venture capital arm of Novartis, investing in innovative life science companies across North America, Europe, and Israel. The fund focuses on pioneering biotechnology and biopharmaceutical companies developing novel therapeutics and platforms to address unmet patient needs, with over USD 750 million in committed capital. | AlestaAnaveonArtios Pharma LimitedAverna Therapeutics | Adam Cotton, PrincipalAnja Koenig, Global Head of NVFBeat Steffen, Managing DirectorFlorian Muellershausen, Managing Director | Startups / Founders (B2B)Professional & Institutional Investors | |
| Novo Holdings | International longevity VCs | Copenhagen, Denmark | Biotech & aging scienceDigital health & AIClinics & care delivery | Novo Holdings is a world-leading life science investor and the wholly owned holding and investment company of the Novo Nordisk Foundation. It focuses on generating long-term returns by investing across various life science segments, including pharmaceuticals, biotechnology, medical technology, and industrial biosolutions, at all stages of development, with a | Novo Nordisk A/SCatalentCoultreon BiopharmaEdgewise Therapeutics, Inc | Christian Mostrup Scheel, Head of Public Relations | Startups / Founders (B2B)Professional & Institutional Investors | |
| Obvious Ventures | Adjacent longevity investors | San Francisco, United States | BiotechCore preventive health | Obvious Ventures is a San Francisco-based venture capital firm founded in 2014, dedicated to backing "world positive" entrepreneurs. The firm invests in early-stage companies across three pillars: Planetary Health, Human Health, and Economic Health, with a specific focus on improving human health and longevity through healthcare, biopharma, and consumer well | Virta HealthBrightside HealthInceptive AIBeyond MeatGusto | Ev Williams, Co-FounderJack Rothacher, Chief Financial OfficerJames Joaquin, Co-Founder & Managing DirectorJessica Nett, Chief of Staff | Startups / Founders (B2B)Professional & Institutional Investors | |
| Octopus Ventures | Adjacent longevity investors | London, United Kingdom | Core preventive health | Octopus Ventures is a prominent venture capital firm based in London, United Kingdom, actively investing in early-stage to growth-stage companies across Europe. The firm focuses on seven key sectors, including Health, demonstrating a commitment to businesses that aim to make a positive impact on people, community, and the environment. | SovaDepopOrbexOmetria | Financial Adviser, Institutional Investor | Startups / Founders (B2B)Professional & Institutional Investors | |
| Offline Ventures | Adjacent longevity investors | Mill Valley, United States | Core preventive health | Offline Ventures is a venture fund and studio that invests in and incubates early-stage technology companies, particularly those focused on humanist technology and enhancing human well-being. The firm invests at pre-seed, seed, and Series A stages, with a focus on companies that integrate online and offline experiences to create healthier and happier lives. | NotionClubhouseOsmindBobbieArc Boats | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Ola Capital | International longevity VCs | Boulder, United States | BiotechCore preventive health | Ola Capital is a venture fund dedicated to bridging the gap between healthspan and lifespan by investing in proactive, personalized health solutions for all ages. The fund focuses on healthy aging and optimizing healthspan, making it highly relevant to preventive health and longevity. | Not captured | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| OrbiMed | Adjacent longevity investors | New York, United States | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care delivery | OrbiMed is a global investment firm focused on the healthcare industry, investing across various stages from early-stage private companies to large multinational corporations. The firm seeks to drive innovation, address unmet medical needs, and improve patient outcomes across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare se | ADARxWindward BioAvenzo Therapeutics | Mona Ashiya, PhD, General PartnerDimitrios Weedon, Managing Director | Startups / Founders (B2B)Professional & Institutional Investors | |
| Overton VC | Adjacent longevity investors | New York, United States | Core preventive health | Overton Venture Capital is a woman-led venture capital fund based in New York, United States, that invests in seed and early-stage, revenue-generating companies. The firm focuses on businesses leveraging technology for digital transformation and next-generation commerce, with a potential relevance to preventive health through its consumer-centric and disrupt | BiomeSenseJoyluxRaydiantGreen Screens | Email Us, Link to INVESTOR RELATIONS portal | Startups / Founders (B2B)Professional & Institutional Investors | |
| OVO Fund | Adjacent longevity investors | Menlo Park, United States | Consumer TechCore preventive health | OVO Fund is a venture capital firm specializing in pre-seed investments, acting as a thought-partner for founders from the earliest stages to IPO. The firm focuses on technology-driven sectors including Digital Health, making it relevant to preventive health and longevity. | 8 unicornsPayjoyAddeparJuniper SquareWellTheoryHarberaFluid Protocol | Eric Chen, Managing PartnerGianfranco Filice, Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Palo Santo | International longevity VCs | Chicago, United States | BiotechCore preventive health | Palo Santo is a Chicago-based venture fund focused on investing in next-generation neuroscience companies developing breakthrough therapeutics and technologies for mental health. The firm targets early-stage opportunities, including pre-seed, seed, and Series A rounds, with a particular emphasis on psychedelic medicines and therapies to address the global me | Gilgamesh PharmaceuticalsAtai Life SciencesBeckley PsytechBexson BiomedicalKsana HealthField Trip HealthDelix Therapeutics | Daniel Goldberg |, Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Panache Ventures | Adjacent longevity investors | Montreal, Canada | Core preventive healthPharma/Drug discoveryWellness Platforms | Panache Ventures is Canada's leading pre-seed and seed fund, investing in visionary entrepreneurs building high-growth technology companies across various sectors. The firm focuses on early-stage investments, providing hands-on support to Canadian founders, with a notable interest in Digital Health and HealthTech. | ACTOALT TEXAgentFieldAltrioFeatherless AI | Domenic Del Vecchio, PrincipalSarah Willson, Principal | Startups / Founders (B2B)Professional & Institutional Investors | |
| Panakes Partners | International longevity VCs | Milan, Italy | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care delivery | Panakes Partners is a Milan, Italy-based venture capital firm focused on early-stage investments in life sciences companies across Europe and Israel. The firm aims to support innovative startups and SMEs developing game-changing technologies that address significant medical needs and improve quality of life. | Vivasure MedicalDISCO PharmaceuticalsAlesi SurgicalNeuromod Devices | Alessio Beverina, Founder and Managing PartnerAlessio Piuma, PrincipalBarbara Castellano, PartnerDiana Saraceni, Founder and Managing Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Partech Partners | Adjacent longevity investors | Paris, France | BiotechConsumer TechCore preventive healthWellness Platforms | Partech Partners is a global venture capital firm that invests in tech and digital companies across seed, venture, and growth stages. The firm has a notable interest in digital health, Health IT, clinical software, and AI/ML in healthcare, making it relevant to preventive health and longevity. | Urban Sports Club | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Pembroke VCT | Adjacent longevity investors | London, United Kingdom | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care deliveryConsumer health & wellness | Pembroke VCT is a London-based venture capital trust established in 2013, managing a fund of approximately £273 million, focused on growth-stage companies in the UK. The fund invests across sectors including wellness, food, beverage & hospitality, digital services, and media, with a notable interest in consumer brands relevant to preventive health and longev | LYMAThrivaPlenishPopsaSmartr365Bolt InsightSecret Food ToursPEAK | View Profile, Investment Director | Startups / Founders (B2B)Professional & Institutional Investors | |
| Pfizer Ventures | Adjacent longevity investors | New York, United States | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care delivery | Pfizer Ventures is the strategic corporate venture capital arm of Pfizer Inc., investing globally in innovative biopharmaceutical companies that are advancing breakthrough medicines. The firm focuses on early-stage investments across a broad range of therapeutic areas and platform technologies aligned with Pfizer's strategic interests. | AnaveonArtios PharmaEnara BioFoRx Therapeutics | Christopher O’Donnell, PhD, Vice President, WWBD / PartnerIrena Melnikova, PhD, Executive Director, WWBD / PartnerMarie-Claire Peakman, MRCPharm, PhD, Executive Director, WWBD / PartnerMichael C. Diem, MD, Vice President, WWBD / Senior Managing Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Phoenix Capital Ventures | Adjacent longevity investors | Atlanta, United States | Core preventive healthWellness Platforms | Phoenix Capital Ventures is a pre-seed and seed-stage venture firm based in Atlanta, United States, investing in technologies that shape how people play, move, compete, and connect. The firm focuses exclusively on sports, fitness, gaming, and entertainment, with its fitness investments holding relevance for preventive health and longevity. | PrizePicksThuuzAttendFlexia | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Picus Capital | Adjacent longevity investors | Munich, Germany | Consumer TechWellness Platforms | Picus Capital is an early-stage technology investment firm based in Munich, Germany, with a global investment approach. The firm focuses on pre-seed, seed, and Series A investments, supporting daring technology companies with a long-term philosophy. It is relevant to preventive health through its investments in the healthcare and techbio sectors. | Enpal | Alexander Samwer, Founding PartnerFlorian Reichert, Partner & Managing DirectorJeremias Heinrich, Founding PartnerJulian Roeoes, Partner Americas | Startups / Founders (B2B)Professional & Institutional Investors | |
| Pivotal bioVenture Partners | Adjacent longevity investors | San Francisco, United States | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care delivery | Pivotal bioVenture Partners is the venture capital arm of Pivotal Life Sciences, a global healthcare investment platform based in San Francisco, United States. It invests in transformative therapeutic-focused healthcare companies across all stages, from company creation to commercialization, with a focus on high-impact therapeutics addressing unmet medical n | Karuna TherapeuticsGrailEngrail TherapeuticsVaxcyte | Ash Khanna, Venture PartnerKaroly Nikolich, Venture PartnerHeather Preston, MD, Managing PartnerPeter Bisgaard, Managing Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Prima Materia | Adjacent longevity investors | Stockholm, Sweden | Biotech | Prima Materia is a European company builder that actively develops new technology-driven companies for the long term, focusing on areas that address significant societal problems. They operate as active owners rather than traditional investors, partnering with exceptional individuals to build businesses. | HelsingEpiternaNeko Health | Daniel Ek, Founder | Startups / Founders (B2B)Professional & Institutional Investors | |
| Primary Venture Partners | Adjacent longevity investors | New York City, United States | Core preventive health | Primary Venture Partners is a New York City-based venture capital firm that specializes in pre-seed and seed-stage investments across various technology sectors, including enterprise software, AI, and healthcare. The firm is relevant to preventive health through its investments in companies focused on mental health, senior living, and other health-related te | AlmaInspirenLyricOllieSpark AdvisorsTabsValerie Health1mind | Kieran Chacko, Incubation Venture PartnerMarcela Sapone, Incubation Venture PartnerBrad Svrluga, Managing Partner, Co-CIOJason Gelman, Operating Partner, Go-to-Market | Startups / Founders (B2B)Professional & Institutional Investors | |
| Project A Ventures | Adjacent longevity investors | Berlin, Germany | Core preventive healthWellness Platforms | Project A Ventures is an early-stage venture capital firm based in Berlin, Germany, that partners with founding teams to build the next generation of European icons. They invest across various sectors, including digital health, at pre-seed, seed, and growth stages, providing both capital and operational support. | KryUnmind11xTrade RepublicSennderQuantum SystemsSprykerZepz | General Counsel, CFO | Startups / Founders (B2B)Professional & Institutional Investors | |
| Pureos Bioventures | Adjacent longevity investors | Pfäffikon SZ, Switzerland | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care deliveryConsumer health & wellness | Pureos Bioventures is a Swiss-based venture capital firm that invests exclusively in private, innovative drug development companies with a primary focus on the next generation of biological drugs and drug formats. The firm targets high-impact therapies for severe diseases across oncology, immunology, ophthalmology, rare diseases, and neuroscience. | Not captured | Dominik Escher, Member of the BoardAnne Grahl, Investment ManagerKlaus Breiner, Managing PartnerMartin Münchbach, Managing Partner | Startups / Founders (B2B)Founded 2018 | |
| RA Capital Management | Adjacent longevity investors | Boston, United States | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care delivery | RA Capital Management is a multi-stage investment manager based in Boston, United States, dedicated to evidence-based investing in public and private healthcare and life science companies. The firm focuses on developing drugs, medical devices, diagnostics, services, and research tools, with a growing interest in climate and sustainability technologies. | 89bioAcumen Pharmaceuticals, IncTyra Biosciences, IncVor Biopharma | ANDREW LEVIN, PhD, PartnerDEREK DiROCCO, PartnerJAKE SIMSON, PartnerJEREMY LACK, DPhil, Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Reach Capital | Adjacent longevity investors | San Francisco, United States | Core preventive health | Reach Capital is an early-stage venture capital firm based in San Francisco, United States, focused on investing in companies that elevate human potential across learning, health, and work. The firm is relevant to preventive health and longevity through its investments in companies redesigning holistic care for longer lives and addressing critical health nee | ClairAsha HealthAblAnthillAprende InstituteCashmerePathfinder | Jennifer Wu, Venture PartnerJim Lobdell, Venture PartnerEsteban Sosnik, Co-Founder & PartnerJames Kim, Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Real Ventures | Adjacent longevity investors | Montreal, Canada | Consumer TechCore preventive healthWellness Platforms | Real Ventures is a leading Canadian early-stage venture capital firm based in Montreal, dedicated to supporting game-changing technology leaders. The firm focuses on nurturing entrepreneurs and the broader Canadian startup ecosystem, with investments spanning various sectors including preventive health and wellness platforms. | Eli HealthLeagueBenchSciTransitXanadudcbelNomic BioNord Quantique | John Stokes, Managing Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Redalpine | Adjacent longevity investors | Zug, Switzerland | Biotech | Redalpine is a thesis-driven venture capital firm founded in 2006, specializing in investments at the confluence of software and science across multiple stages. With Swiss roots and a pan-European approach, the firm actively seeks to empower companies that are improving health for humanity, including those in digital health and biotech. | N26Mistral AI9finHelical | Michael Sidler, Founding PartnerPeter Niederhauser, Founding Partner | Startups / Founders (B2B)Founded 2006 | |
| Redbud Brands | Adjacent longevity investors | Austin, United States | Core preventive health | Redbud Brands is a consumer platform and investment firm that creates, accelerates, and scales innovative consumer brands, with a focus on early-stage investing. The firm is relevant to preventive health and longevity through its portfolio of "better-for-you" consumer packaged goods and wellness-focused companies. | WellcoreMedicine MamaBest BehaviorObviStealth | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Re.Mind | Adjacent longevity investors | Sliema, Malta | Consumer TechWellness Platforms | Re.Mind is an early-stage venture capital firm dedicated to investing in mental health, brain health, and human flourishing. The firm focuses on science- and technology-led companies in areas like neuroscience, digital mental health, and neurotechnology, primarily investing in Seed and Series A rounds across North America and Europe. | Blackrock NeurotechSynchronAlto NeuroscienceTRIPP | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Revent | Adjacent longevity investors | Berlin, Germany | Core preventive health | Revent is an early-stage tech fund based in Berlin, Germany, backing mission-driven founders across Europe. The firm focuses on investments in climate, health, and empowerment, aiming to build generational companies that secure planetary and societal health, making it relevant to preventive health and longevity. | Avelios MedicalOska | Emily Brooke MBE, Venture PartnerFranca Pullem, Investment ManagerHenrik Grosse Hokamp, PartnerLauren Lentz, General Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| R/GA Ventures | Adjacent longevity investors | New York, United States | Consumer TechCore preventive healthWellness Platforms | R/GA Ventures is the corporate venture capital arm and accelerator of R/GA, a global creative agency, investing in products, partnerships, and new ventures that create value for people and brands. It focuses on early-stage companies, from pre-seed to Series B, across various sectors including preventive health, wellness platforms, and consumer tech, leveragi | qiibeeBristleMinti | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Roche Venture Fund | International longevity VCs | Basel, Switzerland | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care delivery | Roche Venture Fund is the corporate venture arm of Roche, a global leader in medicines and in vitro diagnostics, investing in innovative life science companies. Its focus on pharmaceuticals, diagnostics, and digital health aims to prevent, stop, and cure diseases, aligning with preventive health and longevity goals. | AligosCivi BiopharmaDiogenXSpliceBio | Alan Hippe, Chief Financial OfficerCristina A. Wilbur, Chief People OfficerMatt Sause, CEO Roche DiagnosticsTeresa Graham, CEO Roche Pharmaceuticals | Startups / Founders (B2B)Professional & Institutional Investors | |
| Rock Health Capital | International longevity VCs | San Francisco, United States | Core preventive health | Rock Health Capital is a venture capital firm that invests in early-stage digital health companies at the intersection of healthcare and technology, with a mission to improve healthcare for all. Its focus on technology-driven solutions and digital health innovations makes it highly relevant to preventive health and longevity. | Omada HealthBurstNo Barrier AIOurs Privacy for HIPAA-safe marketing and analyticsPear SuiteBeam Dental | Startups / Founders (B2B)Professional & Institutional Investors | ||
| Route 66 | Adjacent longevity investors | Alexandria, United States | Core preventive health | Route 66 Ventures is a venture capital firm based in Alexandria, Virginia, that invests in early-stage companies focused on digital health and wellness and financial technology. The firm emphasizes supporting innovations that drive positive change, particularly in advancing wellbeing and improving human healthspan through preventive approaches. | ClearmaticsDriveWealthMotionsoftPayzerRippleMirror | Benjamin Britt, Managing PartnerEric Dobosh, PrincipalStuart Fox, Chief Financial OfficerMichael Casalett, Vice President of Finance | Startups / Founders (B2B)Professional & Institutional Investors | |
| Salica Investments | Adjacent longevity investors | London, United Kingdom | Biotech & aging scienceDigital health & AIClinics & care deliveryConsumer health & wellness | Salica Investments is a London-headquartered international investment firm that evolved from Hambro Perks, focusing on private market funds across various sectors and stages. The firm invests in digital technology, environmental innovations, healthcare, and MENA opportunities, with a strong emphasis on growth from seed to scaling. | DoctolibOutcomes4MeLindus HealthGelesisKigenTide | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Samsara BioCapital | Adjacent longevity investors | Palo Alto/San Francisco Bay Area, United States | Biotech & aging scienceDigital health & AIClinics & care delivery | Samsara BioCapital is a venture capital firm focused on investing in transformative therapeutics for patients across public and private life science companies. The firm aims to back the next generation of therapeutic breakthroughs, with a patient-first mentality and a long-term investment horizon. | A2 Biotherapeutics, IncAbivax SAIO Biotech, IncArtiva Biotherapeutics | Betsy Santos, Venture Partner, Chief People OfficerDavid Parry, Venture PartnerEric Dobmeier, JD, Venture PartnerGuna Rajagopal, Venture Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Sanofi Ventures | Adjacent longevity investors | Cambridge, United States | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care delivery | Sanofi Ventures is the corporate venture capital arm of Sanofi, investing in top-tier biotherapeutic and digital health companies globally. They focus on early-stage transformational science and technology, from Seed to Series B and beyond, aiming to improve human health and transform the healthcare system. | AbcuroAtalanta TherapeuticsExpedition TherapeuticsReCode Therapeutics | Startups / Founders (B2B)Professional & Institutional Investors | ||
| Santo Holding | Family Offices & UHNW Investors | Zug, Switzerland | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care delivery | Santo Holding is the high-impact investment vehicle of the Strüngmann family, brothers Andreas and Thomas, who utilize their multi-billion dollar healthcare fortune to back transformative biotechnologies and life science platforms. Based in Switzerland, the firm is renowned for its early and decisive support of mRNA leader BioNTech and its long-term commitme | Not captured | Not captured | Startups / Founders (B2B)Founded 2001 | |
| Second Sight Ventures | Adjacent longevity investors | Los Angeles, United States | Digital health & AIClinics & care deliveryConsumer health & wellness | Second Sight Ventures is an early-stage venture capital firm based in Los Angeles, United States, focused on investing in consumer brands and technology companies. The firm targets businesses where culture creates a significant competitive advantage, with several investments aligning with preventive health and wellness through CPG products. | PoppiLemmeLucky EnergyTally Health | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Seedcamp | Adjacent longevity investors | London, United Kingdom | BiotechCore preventive healthPharma/Drug discovery | Seedcamp is a leading European early-stage venture fund based in London, investing in ambitious founders from pre-seed to seed stages. The firm focuses on technology companies across various sectors, including healthtech, demonstrating relevance to preventive health and longevity. | Function HealthBioOrbitPeppyLindus HealthRevolutWiseSynthesiaUiPath | Carlos Eduardo Espinal, Managing PartnerFelix Martinez, PrincipalReshma Sohoni, Co-Founder & Managing PartnerSia Houchangnia, Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Selva Ventures | Adjacent longevity investors | Los Angeles, United States | Core preventive health | Selva Ventures is a venture capital firm established in 2019, based in Los Angeles, California, that invests in early-stage branded consumer products focused on healthier living. The firm's thesis centers on the significant role of the consumer economy in advancing health, wellness, and longevity. | GrünsOneSkinNative PetArraeSurelyFoodNerd | Doug Waller, OPERATING PARTNERKiva Dickinson, FOUNDER & MANAGING PARTNERMadeline Kaplan, PARTNERMatt Gornstein, OPERATING PARTNER | Startups / Founders (B2B)Professional & Institutional Investors | |
| Seventure Partners - Health for Life Capital | International longevity VCs | Paris, France | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care deliveryConsumer health & wellness | Seventure Partners is a leading European venture capital firm established in 1997, specializing in financing innovative companies in Life Sciences and Digital Technologies. It has a strong focus on microbiome, nutrition, and digital health, investing across all stages from seed to growth capital, primarily in Europe, but also in North America, Israel, and As | EnteromeTargedysEligo BioscienceDayTwoCorWaveStanding OvationIDnow | Emmanuel Fiessinger, Senior Partner in the Lifesciences teamIsabelle de Cremoux, CEO and Managing PartnerAbout Seventure, Our Investment Strategy | Startups / Founders (B2B)Professional & Institutional Investors | |
| Skalata | Adjacent longevity investors | Melbourne, Australia | Core preventive healthWellness Platforms | Skalata is an early-stage venture capital firm based in Melbourne, Australia, known for its high support-to-cheque size ratio for pre-seed startups. The firm focuses on providing patient capital and hands-on support to help companies build strong fundamentals, with a notable investment in mental health management aligning with preventive health. | InitiallySupports primary school teachers bynot provided in the snippets | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Sofinnova Partners | Adjacent longevity investors | Paris, France | Pharma/Drug discovery | Sofinnova Partners is a leading European venture capital firm specializing in life sciences, with a focus on healthcare and sustainability. The firm invests across all stages, from seed to later-stage, in breakthrough innovations that aim to improve people's health and well-being globally. | CellCentricMarea TherapeuticsCOPDRefleXionHOOKIPA PharmaTenpoint Therapeutics | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| SOSV | Adjacent longevity investors | San Francisco, United States | Biotech | SOSV is a global deep tech venture capital firm that invests at the pre-seed stage and beyond, focusing on startups with a profound impact on human and planetary health. Their extensive human health portfolio includes companies developing therapeutics, diagnostics, remote care, biomanufacturing, and solutions for longevity and women's health. | RAWGAOneSkinHelexLightHearted AISamphire NeuroscienceCell Bioengines | Shawn Broderick, Venture PartnerCyril Ebersweiler, General PartnerMohan S. Iyer, General PartnerPae Wu, General Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Speedinvest Health | Adjacent longevity investors | Vienna, Austria | BiotechCore preventive health | Speedinvest Health is the dedicated health and bio investment team of Speedinvest, a European venture capital firm. It focuses on early-stage health tech, bio, and life sciences startups that leverage AI/ML to improve healthcare outcomes, access, and cost of care, with a strong relevance to preventive health and longevity. | Orakl OncologyDoctorly | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Spero Ventures | Adjacent longevity investors | Burlingame, United States | BiotechCore preventive healthPharma/Drug discovery | Spero Ventures is a boutique venture capital firm based in Burlingame, United States, investing in purpose-led companies at Seed and Series A stages. The firm focuses on technology solutions that contribute to a healthy, sustainable, and fulfilling future, making it relevant to preventive health and longevity. | Not captured | Marc Tarpenning, Venture PartnerAndrew Parker, General PartnerSara Eshelman, General PartnerShripriya Mahesh, General Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Superhero Capital | Adjacent longevity investors | Helsinki, Finland | BiotechCore preventive healthWellness Platforms | Superhero Capital is a Helsinki, Finland-based venture capital fund that provides seed funding to software-driven startups in the New Nordics, with investments typically up to 1M€. The firm demonstrates relevance to preventive health through its portfolio companies, including a clinical intelligence platform and a camera-based health diagnostics platform, al | MX LabsDoublepointCactos | Ivo Remmelg, Venture Partner, EstoniaAudrius Milukas, Partner, LithuaniaGytenis Galkis, Partner, LithuaniaJakob Storå, General Partner, Finland | Startups / Founders (B2B)Professional & Institutional Investors | |
| Swisscom Ventures | Adjacent longevity investors | Worblaufen, Switzerland | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care deliveryConsumer health & wellness | Swisscom Ventures is the venture capital arm of Swisscom AG, focused on investing in high-potential technology startups across digital health, ICT, and deeptech. The firm provides minority stakes, technical infrastructure access, and go-to-market support for both Swiss university spin-offs and international growth-stage companies. | Not captured | Alexander Schlaepfer, Investment PartnerJennifer McCloskey, Investment DirectorKlea Wenger, Investment DirectorPär Lange, Investment Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| SwissHealth Ventures (CSS Group) | Adjacent longevity investors | Luzern, Switzerland | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care deliveryConsumer health & wellness | SwissHealth Ventures serves as the corporate venture capital branch of the CSS Group, focusing on strategic investments in digital health startups that enhance healthcare efficiency and sustainability. The organization specifically targets growth-phase companies that align with the CSS Group’s mission to provide high-quality, cost-effective healthcare to its | Not captured | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Target Global VC | Adjacent longevity investors | Berlin, Germany | Consumer TechWellness Platforms | Target Global is a pan-European technology investment firm headquartered in Berlin, Germany, with over €3 billion in assets under management. The firm invests across all stages, from pre-seed to pre-IPO, focusing on transformational technology companies, including those in the healthtech sector. | RapydDelivery HeroRevolutWefoxFreshaAuto1 GroupCopperFlink | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Tenity | Adjacent longevity investors | Zurich, Switzerland | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care deliveryConsumer health & wellness | Tenity is a global innovation powerhouse and early-stage venture capital firm headquartered in Zurich, focusing on fintech and digital health. The organization operates six global hubs and employs a hybrid model that combines innovation partnerships with corporate giants and specialized accelerator programs to foster growth in high-impact technology sectors. | Not captured | Case Studies, Explore Venture Capital | Startups / Founders (B2B)Founded 2015 | |
| The Artemis Fund | Adjacent longevity investors | Houston, United States | Core preventive healthWellness Platforms | The Artemis Fund is a Houston-based venture capital firm that invests in early-stage, women-led technology companies across the United States. The fund focuses on sectors like fintech, e-commerce infrastructure, and care technology, with several portfolio companies directly addressing preventive health, maternal health, chronic condition management, and well | Salvo HealthSimpliFedAvela HealthHopSkipDriveHello Divorce | Susan Keating, CEO, Board Risk CommitteeAdrienne Mangual, Chief Financial OfficerAlisha Loos, Finance Operating PartnerDiana Murakhovskaya, General Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| The Column Group | Adjacent longevity investors | San Francisco, United States | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care delivery | The Column Group (TCG) is a San Francisco-based venture ecosystem and science-driven venture capital firm dedicated to fueling scientific innovation in the life sciences industry. TCG employs an edge-to-edge investment model, supporting early technology platforms, single assets, and later-stage programs from inception through exit, with a focus on building f | TopoSurrozenRevolution MedicineMonimoi Therapeutics | Arnav Mehta, MD, Venture PartnerCraig Parker, Venture PartnerCarla Daniel, Partner & Chief People OfficerCharles Sawyers, Science Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| The Venture City | Adjacent longevity investors | Miami, United States | Consumer TechWellness Platforms | The Venture City is a global early-stage venture capital firm that invests in mission-driven and diverse founders, focusing on companies leveraging unique data and AI for product-led growth. They primarily invest in Series A rounds, with a notable interest in the Life Science and Health sector, making them relevant to preventive health and longevity. | AidalyHogaruEmprego Ligado1DOC3 in Latin AmericaAbove & BeyondRecargaPay | Andrés Dancausa, General Partner, Series AClara Bullrich, Co-Founder, General PartnerDavid Smith, Operating Partner - DataGuillermo Cortina, Operating Partner - M&A | Startups / Founders (B2B)Professional & Institutional Investors | |
| Third Rock Ventures | Adjacent longevity investors | Boston, United States | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care delivery | Third Rock Ventures is a leading healthcare venture firm focused on discovering, launching, and building transformative life science companies. They aim to translate scientific discoveries into breakthrough medicines to address unmet medical needs and significantly impact patients' lives. | Otarmeni™Syremis TherapeuticsMerida BiosciencesNurix Therapeutics | Abbie Celniker, PhD, PartnerKevin Gillis, PartnerNeil Exter, PartnerReid Huber, PhD, Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Time BioVentures | Adjacent longevity investors | Southern California, United States | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care delivery | Time BioVentures is a venture capital firm based in Los Angeles, California, specializing in early and growth-stage investments across the healthcare and life sciences sectors. The firm focuses on financing game-changing technologies aimed at extending patients' health and lifespan. | Phantom NeuroBrightside HealthConceivable Life SciencesCS GeneticsKling Biotherapeutics | D.A. Wallach, General PartnerTim Wright, MD, General PartnerRyan Moriarty, Associate | Startups / Founders (B2B)Professional & Institutional Investors | |
| Torch Capital | Adjacent longevity investors | New York, United States | Core preventive healthWellness Platforms | Torch Capital is a New York-based early-stage venture capital firm that invests in AI-powered companies transforming how consumers and businesses operate. The firm's portfolio includes investments in healthcare and wellness platforms, demonstrating its relevance to preventive health and longevity. | RoAcornsTiaSollis HealthLili BankLittle Otter | Chris Harper, PartnerJake Moross, PrincipalJonathan Keidan, Founder & Managing PartnerKatie Peykar, Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Town Hall Ventures | International longevity VCs | New York, United States | Core preventive health | Town Hall Ventures is a New York-based venture capital firm founded in 2018, focused on investing in healthcare technology and services companies that address the needs of underserved communities and vulnerable populations in the United States. The firm aims to transform poorly served parts of the healthcare system, aligning with preventive health by improvi | VillageMDCityblock HealthUnite Us | Andy Slavitt, General PartnerAnna Fagin, PartnerDavid Whelan, General PartnerJoann Barsky, Chief Financial Officer and Head of Operations | Startups / Founders (B2B)Professional & Institutional Investors | |
| Union Square Ventures | Adjacent longevity investors | New York City, United States | BiotechCore preventive healthWellness Platforms | Union Square Ventures (USV) is a New York City-based venture capital firm that invests in early-stage companies at the edge of large markets being transformed by technological and societal pressures. The firm has a specific interest in health-related technologies, particularly those enabling individual, self-directed healthcare and the unbundling of traditio | EtsyStripeCoinbaseRupaAbridgeModern FertilityScanwellIsembard | Albert Wenger, PartnerAndy Weissman, Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| UPMC Enterprises | Adjacent longevity investors | Pittsburgh, United States | Core preventive health | UPMC Enterprises is the innovation, commercialization, and venture capital arm of UPMC, a major healthcare provider and insurer based in Pittsburgh, PA. It focuses on investing in and developing healthcare innovations, particularly in digital solutions and translational sciences, to improve lives by making healthcare more efficient, affordable, and personali | Not captured | Not captured | Startups / Founders (B2B)Professional & Institutional Investors | |
| Versant Ventures | International longevity VCs | San Francisco, United States | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care delivery | Versant Ventures is a global venture capital firm established in 1999, specializing in the creation and financing of novel biotechnology companies. The firm focuses on early-stage through later biotech financing, leveraging in-house discovery engines and academic partnerships to drive scientific advancements in healthcare. | Jazz PharmaceuticalsInari MedicalCRISPR TherapeuticsBlueRock Therapeutics | Alicia Levey, Venture PartnerAndrew Jefferson, Operating PartnerGiorgio Ottaviani, Operating PartnerAlex Mayweg, Managing Director | Startups / Founders (B2B)Professional & Institutional Investors | |
| Verve Ventures | Adjacent longevity investors | Wettingen, Switzerland | BiotechPharma/Drug discovery | Verve Ventures is a European deep tech venture capital firm that has been investing for 15 years in transformative companies across Health & Bio, Future of Computing, and Energy & Resources. The firm focuses on early to growth-stage investments, providing capital and strategic support to startups. Its "Frontiers in Health & Bio" focus, including digital heal | IkerianOrakl OncologyEcorobotix | Friederike Reinl, Partner, Head of Investor RelationsLucas Laib, Partner, COOLukas Weber, Partner, CEOSteffen Wagner, Partner, CEO | Startups / Founders (B2B)Founded 2010 | |
| Vida Ventures | Adjacent longevity investors | Los Angeles, United States | Pharma/Drug discovery | Vida Ventures is a next-generation life sciences investment firm focused on transforming biomedical innovations into therapies. The firm invests across various stages in companies developing groundbreaking science within the therapeutics and life science sectors. | Candid TherapeuticsHalda TherapeuticsCapstan TherapeuticsInduProAktis OncologyA2 BiotherapeuticsAdcendo ApS | Arie Belldegrun, Founder and Senior Managing DirectorJoshua Kazam, Co-Founder and DirectorAlessandro Giacometti, Vice President, Head of Investor RelationsCortney Elms, Senior Accounting Associate | Startups / Founders (B2B)Professional & Institutional Investors | |
| VI Partners | Adjacent longevity investors | Altendorf, Switzerland | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care deliveryConsumer health & wellness | (Confidence level: high) VI Partners is Switzerland’s longest-standing venture capital firm, founded in 2001 to support technology and healthcare innovation. The firm specializes in early-stage, deep-tech spin-offs from Swiss federal institutes (ETH Zurich, EPFL) and research institutions, providing capital and strategic guidance to visionary entrepreneurs.1 | Not captured | Arnd Kaltofen, Managing PartnerCyrill Osterwalder, Operating PartnerDiego Braguglia, Managing PartnerGaetano Zanon, Managing Partner | Startups / Founders (B2B)Researchers / Scientific CommunityFounded 2001 | |
| VMG Partners | Adjacent longevity investors | San Francisco, United States | Wellness Platforms | VMG Partners is a private equity firm based in San Francisco, United States, specializing in growth-stage investments in branded consumer products and services, as well as early to Series C stage technology companies serving the consumer ecosystem. The firm's focus on wellness, fitness, and personal care brands makes it relevant to preventive health and long | Drunk ElephantQuestSpindriftSun BumKindSolidcorePill Club | Alisa (Williams) Carmichael, PartnerEliza Becker, PrincipalMcConnell Smith, General PartnerAllen Sha, Associate | Startups / Founders (B2B)Professional & Institutional Investors | |
| Vorwerk Ventures | Adjacent longevity investors | Berlin, Germany | Core preventive health | Vorwerk Ventures is an independent venture capital fund based in Berlin, Germany, focusing on early-stage investments in technology companies. The firm backs founders who drive positive change for people and the planet, with a specific interest in consumer, food-agtech, healthcare, and climate solutions, making it relevant to preventive health and longevity. | Sqior, sorellaOttonovaFORMEL SkinAvi Medical | Dirk Meurer, Managing PartnerHanna Villa, Investment ManagerKatharina Man, PrincipalNorbert Muschong, Managing Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Westlake BioPartners | Adjacent longevity investors | Los Angeles, United States | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care delivery | Westlake BioPartners is a people-first life science venture capital firm that incubates and crafts companies around world-class entrepreneurs. They focus on turning breakthroughs into treatments for patients, investing in early-stage biotechnology companies from ideation and preclinical research through clinical and commercial patient impact. | AllRock BioCapsidaTmunity Therapeutics | Beth Seidenberg, Founding Managing DirectorDavid Allison, Managing DirectorMira Chaurushiya, Managing Director | Startups / Founders (B2B)Professional & Institutional Investors | |
| Wildwood | Adjacent longevity investors | Denver, United States | Core preventive health | Wildwood is an early-stage venture capital firm and venture studio based in Denver, United States, investing in technology startups that promote healthy and active humanity. It focuses on personalized, preventive, and accessible solutions within the outdoor and wellness economies, addressing societal challenges like sedentary living and loneliness. | Kinsa ActiveChimaniRoots | Amy Maher, Principal and Head of ProductDavid Krasny, Principal and Head of GrowthDavid Wagner, Founder and Managing PartnerJesse Marble, Founder and Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Willow Growth Partners | Adjacent longevity investors | Malibu, United States | Core preventive health | Willow Growth Partners is an early-stage venture capital firm that invests in next-generation, values-led consumer brands. The firm focuses on sectors including beauty, personal care, food & beverage, health & wellness, baby, home, and pet products, with a strong emphasis on companies promoting a wellness-oriented lifestyle. They typically lead the first ins | GoodlesBubbleManscapedMaevPerelelseveral consumer brands, some of | Deborah Benton, Founder & Managing Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| XFactor Ventures | Adjacent longevity investors | Boston, United States | Core preventive health | XFactor Ventures is a venture fund that provides pre-seed and seed-stage capital to companies founded by women and mixed-gender teams, aiming to build billion-dollar companies. The fund has a broad investment focus, including digital health, and is relevant to preventive health through its portfolio. | Shiru | Aubrie Pagano, General Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| XRC Ventures | Adjacent longevity investors | New York, United States | Core preventive healthWellness Platforms | XRC Ventures is a New York-based pre-seed to Series A venture capital firm and startup accelerator, investing in the future of retail, consumer, and commerce technology. The firm also focuses on solutions that improve worker well-being, safety, and productivity, demonstrating relevance to preventive health. | Ash WellnessSoWell Health, another relevant health-focused companyBillieMD Integrations | Pano Anthos, Founder & Managing Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Zürcher Kantonalbank (ZKB) | Adjacent longevity investors | Zurich, Switzerland | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care delivery | Zürcher Kantonalbank (ZKB) is Switzerland's leading cantonal bank and a major institutional player in the longevity economy.19 Through its asset management arm, Swisscanto, it offers specialized investment products targeting the demographic shift and provides venture capital to the next generation of Swiss longevity startups.21 | Not captured | Not captured | Startups / Founders (B2B)Founded 2005 |
| Category | Definition | Examples | Investors |
|---|---|---|---|
| Funds (Tech, Bio, Crypto) that do not exclusively target longevity but have a significant track record of investing in the sector. | 25M Health, .406 Ventures, 5AM Ventures, Able Partners, Accel | 190 | |
| Private wealth management entities actively deploying capital into the longevity ecosystem (direct deals or via funds). | B-Flexion, Santo Holding | 2 | |
| Foreign venture capital funds that are highly active in the Swiss ecosystem, co-investing with Swiss funds or funding Swiss startups. | 7Wire Ventures, age1, Amboy Street Ventures, Amino Collective, Andera Partners Life Sciences | 64 | |
| Swiss-based investment vehicles with a specific, declared mandate to invest in the longevity, geroscience, or healthy aging sectors. | Helvetic Trust – Longevity Investment Solutions, Korify Capital, Longevity Fund by Clinique La Prairie | 3 | |
| Investment firms and company builders dedicated to funding and creating startups in the longevity and geroscience sectors. | Maximon | 1 |
| Focus area | What it captures | Representative investors | Investors |
|---|---|---|---|
| Biotech & aging science | Investors backing therapeutics, aging biology, regenerative medicine, drug discovery, and platform biotech. | 64 | |
| Diagnostics & biomarkers | Capital providers connected to diagnostics, omics, biomarker testing, clinical labs, and longitudinal measurement. | 51 | |
| Digital health & AI | Investors exposed to software, digital care, AI, remote monitoring, health platforms, and data infrastructure. | 71 | |
| Clinics & care delivery | Investors around preventive health, clinic groups, medical longevity centers, and care-delivery platforms. | 71 | |
| Consumer health & wellness | Capital providers backing consumer longevity, wellness, performance, supplements, and health optimization brands. | 39 |
This investor map is a research draft for informational purposes only. Investor strategy, portfolio exposure, fund status, and links may change over time and should be independently verified before editorial, investment, fundraising, or partnership decisions.
Desktop only
Research is currently available on desktop only.
The Research module is designed for larger screens. Please reopen it on a desktop or laptop to use the screener, filters, detail pages, and admin tools.